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Zusammenfassung 
 
Die universelle Clathrin schwere Kette (CHC17) ist seit langem als Hüllprotein in 
Transportvorgängen, insbesondere der Clathrin-vermittelten Endozytose bekannt. 
Weiterhin konnte eine Rolle für CHC17 im Aufbau der mitotischen Spindel nachgewiesen 
werden. Clathrin schwere Kette 22 (CHC22) ist eine Isoform von CHC17, welche in allen 
Geweben schwach, in Skelettmuskel hingegen stark exprimiert wird. Obwohl zu 85 % 
identisch mit CHC17, wurde bislang keine Funktion für CHC22 gefunden. 
 
In dieser Arbeit wird die Funktion von CHC22 als unabhängig von CHC17 definiert, auch 
kann CHC22 CHC17 nicht bei dessen Verlust ersetzen. CHC22 wird dagegen eine Rolle 
in einem CHC17-unabhängigen endosomalen Sortierungsvorgang zugewiesen. Dieser 
wird von ausgewählten Frachtmolekülen, unter anderem den Mannose-6-Phosphat 
Rezeptoren und Shiga-Toxin beim Transport von Endosomen zum Trans-Golgi Netzwerk 
genutzt. Der CHC22-abhängige Schritt folgt CHC17- und retromer-abhängigen nach.  
 
In humanen Muskelzellen konnte eine Funktion von CHC22 für die Bildung GLUT4-
speichernder Sekretvesikel gezeigt werden. CHC17 spielt hingegen keine Rolle in deren 
Aufbau.  GLUT4-speichernde Sekretvesikel sind abhängig von Membrantransport aus 
dem Endosom und dem Trans-Golgi Netzwerk stammend. Verlust von CHC22 führt zum 
Verlust GLUT4-speichernder Vesikel. Gleichzeitig verlieren die Zellen ihre Insulin-
reaktivität hinsichtlich Zuckeraufnahme, was die Wichtigkeit von CHC22 unterstreicht.  
 
Schlagwörter: Clathrin, Membrantransport, Endosom 
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Abstract 
 
The ubiquitous clathrin heavy chain, CHC17, is well characterized as a coat protein in 
membrane traffic, particularly its role in receptor-mediated endocytosis has been studied 
in great detail. In addition, a role for CHC17 in formation of the mitotic spindle has been 
described. Clathrin heavy chain 22  (CHC22) is an isoform of CHC17 present in all 
tissues with increased expression in skeletal muscle. Despite exhibiting 85 % sequence 
identity to CHC17, CHC22 function remained elusive so far.  
 
In this study CHC22 function is revealed to be independent of CHC17. Also, CHC22 may 
not compensate for loss of CHC17 in either CHC17-mediated membrane trafficking or 
formation of the mitotic spindle. Instead, CHC22 functions in a discrete endosomal 
sorting step required by select cargo molecules including mannose-6-phosphate 
receptors and Shiga-toxin for retrograde trafficking from endosomes to the trans-Golgi 
network. This sorting step occurs downstream of CHC17- and retromer-mediated 
retrograde sorting at the early endosome.  
 
In skeletal muscle CHC22 is found to be required for function of the insulin-responsive 
GLUT4 storage compartment. In contrast, function of this compartment is CHC17-
independent. The GLUT4 storage compartment depends on delivery of the glucose 
transporter 4 from endosomes and the trans-Golgi network. Depletion of CHC22 leads to 
complete loss of this compartment alongside loss of insulin responsiveness regarding 
glucose uptake in skeletal muscle, highlighting CHC22s importance in this pathway. 
 
Key words: clathrin, membrane traffic, endosome 
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Abbreviations 
 
 
aa Amino acid 
Akt Thymoma viral proto-oncogene 1 
AP Adaptor protein 
BFA Brefeldin A 
BSA Bovine serum albumine 
bp Base pair 
CHC Clathrin heavy chain 
CI-MPR Cation-independent mannose-6-phosphate receptor 
CMV Cytomegalovirus 
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DAPI 4-6-diamidino-2-phenylindole 
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DMEM Dulbeccos Modified Eagles Media 
DNA Deoxyribonucleic acid 
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EDTA Ethylene diamine tetraacetic acid 
EE Early endosome 
EGF Epidermal growth factor 
EGF-R Epidermal growth factor receptor 
ER Endoplasmatic reticulum 
Abbreviations 
  
10 
FBS Fetal bovine serum 
GFP Green fluorescent protein 
GGA Golgi-localized, -earcontaining Arf-binding proteins 
GLUT4 Glucose transporter 4 
GSC GLUT4 storage compartment 
HA Hemagglutinin 
HEPES 4-(2-hydroxylethyl)-1-piperazine-ethanesulphonic acid 
His-tag 6 x histidin protein tag 
HRP Horseradish peroxidase 
IF Immunofluorescence 
Ig Immunoglobulin 
kDa Kilo Dalton 
LE Late endosome 
LHCNM2 lox-hygo-hTERT Cdk4-neo, subclone male 2 
M6PR Mannose-6-phosphate receptor 
PAGE Polyacryamide gelelecrophoresis 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
Pen Penicillin 
PIP Phosphatidyl inositole 
RNA Ribonucleic acid 
RNAi RNA interference 
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SDS Sodium dodecyl sulfate 
siRNA Small interfering RNA 
SNARE soluble N-ethylmaleimide-sensitive factor attachment receptor 
SNX Sorting nexin 
Strep Streptomycin 
STX syntaxin 
STxB Shiga-Toxin subunit B 
TBS-T Tris buffered saline containing Tween20 
Tfr Transferrin 
Tfr-R Transferrin receptor 
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Chapter 1 - Introduction 
 
Intracellular membrane transport 
 
Eukaryotic cells are compartmentalized allowing for the creation of different reaction 
conditions within a single cell. The varying compartments formed are separated by 
membranes consisting of lipid bilayers. Therefore, resulting organelles are individualized 
forming specific water-based reaction milieus. However, this compartmentalization 
requires dedicated transport processes for nutrients, lipids or proteins to cross organelle 
boundaries. The transport of lipid bilayers and its enclosed cargo is collectively termed 
membrane transport. Membrane transport is required both for soluble and membrane-
bound molecules. Transport is mainly achieved in small vesicles of 0.05 – 0.2 μm 
diameter, although some exceptions exist. The composition, generation, sorting and 
fission of transport vesicles is a highly regulated process, involving a multitude of 
proteins, the interplay of which defines the exact nature of a transport vesicle. Failure to 
correctly traffic cargo, due to malfunction of its regulatory machinery has been 
demonstrated to result in a number of diseases. 
 
Coat proteins 
A key role in vesicular transport is played by coat proteins that are found on the surface 
of transport vesicles. The most extensively characterized coat is the clathrin coat, that is 
involved in transport emanating from the Golgi apparatus, endosomes and the plasma 
membrane. However, other coats mediate traffic between the endoplasmatic reticulum 
(ER) and the Golgi apparatus. Notably, distinct coats act in ER to Golgi and Golgi to ER 
Chapter 1 – introduction 
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trafficking, making these coats far more specific. Furthermore, membrane transport 
processes have been described that occur without coat proteins.  
 
The clathrin coat 
 
This work concentrates on the function of clathrin heavy chain 22 (CHC22). This protein 
is the only human homologue to the well-characterized clathrin heavy chain 17. To 
understand CHC22-function I will introduce CHC17-function first, since large parts of this 
work compare the two clathrin heavy chains and understanding CHC17 is pivotal for 
understanding CHC22. The two variants were named for their respective encoding 
human chromosomes.  
The clathrin coat is the best understood coat (Brodsky et al., 2001; Kirchhausen, 2000). 
Clathrin cages consist of pentagonal and hexagonal structures that form cages of 
varying size, depending on the membrane vesicle transported. The cage structure has 
been compared to soccer balls, fullerenes and Buckminster spheres. Several models of 
clathrin cages based on electron cryomicroscopy and crystal structures of discrete 
domains have been described (Fotin et al., 2004; Smith et al., 1998; ter Haar et al., 
1998; Ybe et al., 1999). The best model available has a resolution of 12.5 Å (Fig. 1-1A). 
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The functional unit of clathrin cages is the clathrin triskelion, named after its three-legged 
shape (Ungewickell and Branton, 1981). Assembly of triskelia into flat lattices on 
membranes and subsequent invagination of the lattice has been demonstrated to drive 
vesicle budding (Hinrichsen et al., 2006). Each triskelion consists of three CHC17 
molecules that associate via their c-terminal trimerization domains (Fig. 1-1B). Triskelia 
are very stable and no monomeric CHC17 can be found in cells. In addition, each 
CHC17 binds one clathrin light chain molecule (CLC) via its proximal leg domain. Two 
variants of CLCs termed CLCa and CLCb exist in mammals. Their relative expression is 
tissue-dependent with splice variants present in neurons. Few functional differences 
have been observed. CLCb binds CHC17 with slightly higher affinity in vitro (Acton and 
Brodsky, 1990). However, both CLCs inhibit spontaneous triskelia assembly under 
physiological conditions and are therefore considered to be negatively regulators of cage 
assembly. In addition, CLCs bind to Huntingtin-interacting protein 1 (Hip1) and Hip1-
Fig. 1-1: Clathrin cages are formed of clathrin heavy chain. (A) Clathrin cage at 12.5 Å 
resolution (Fotin et al., 2004). Single triskelia are highlighted. (B) Domain structure of clathrin 
heavy chain 17 (Wilbur et al., 2005). Note that in this depiction 45 amino acids are missing from 
the c-terminus.  
Chapter 1 – introduction 
  
17 
related protein (Hip1R), which in turn bind actin (Chen and Brodsky, 2005). Thus CLCs 
provide a bridge between budding vesicles and the actin cytoskeleton.  
CHC17 does not bind membranes or membrane proteins directly. Contacts between 
CHC17 and the membrane are mediated by adaptor proteins. The interplay of various 
adaptor proteins is required for regulation and sorting specificity in clathrin-mediated 
transport.  
 
Adaptor proteins for clathrin mediated vesicular trafficking 
 
Numerous proteins have been described that modulate sorting of cargo and influence 
clathrin mediated vesicle budding (Benmerah and Lamaze, 2007; Owen et al., 2004; 
Ungewickell and Hinrichsen, 2007). Here, I will concentrate on two subsets of adaptors 
that play key roles in recognizing cargo, and establishing connections between cargo 
and clathrin, namely tetrameric adaptor proteins 1-3 (AP1-3) and monomeric Golgi-
localized, -earcontaining Arf-binding proteins 1-3 (GGA1-3) (Fig 1-2).  
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The adaptor proteins AP1-3 consist of four subunits each that all display high homology 
among each other. All three adaptors recognize cargo, bind specific lipids and interact 
with CHC17. Their respective specificities for cargo and lipids result in differing 
localization within the cell. AP1 and AP3 act in clathrin-mediated sorting at the TGN and 
endosomes, while AP2 acts in clathrin-mediated endocytosis from the plasma 
membrane. AP2 function is best understood, but AP1 and AP3 are thought to act in 
similar fashion at their respective localizations. Adaptor proteins not only interact with 
cargo and membranes on the one hand and clathrin on the other, but they also interact 
with several accessory proteins. Accessory proteins are required for recognition of 
specific subsets of cargo and regulation of clathrin coat formation. At least some 
functions of adaptor proteins are regulated by phosphorylation resulting in affinity 
changes for various binding partners. The interplay of numerous weak interactions 
surrounding adaptor proteins are thought to result in initiation of a vesicle trafficking 
event. Interestingly, a fourth adaptor protein complex, AP4, has been described but this 
Fig. 1-2: Classes of adaptors: left: tetrameric adaptor protein complex exemplified by AP1. 
right: monomeric GGA adaptor. Note the similarities in clathrin binding region 
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complex does not bind CHC17 and is thought to be required for clathrin-independent 
trafficking steps.  
GGAs are a separate class of adaptor proteins found at the TGN and endosomes. They 
qualify as adaptor proteins since they bind both cargo and CHC17 (Bonifacino, 2004). 
There are three GGAs in humans (GGA1-3) but few differences have been described 
between them. GGA1 and GGA3 can be autoinhibited, while GGA2 seems to be in a 
constitutively active form. GGAs have been shown to act cooperatively in cargo sorting 
at the TGN and GGA1 also interacts with AP1 (Bai et al., 2004; Ghosh et al., 2003b). 
However, both GGAs and AP1 bind the same motifs in cargo molecules and it is 
unknown if they act synergistically in cargo sorting or if they compete for cargo binding. 
An interesting feature of GGAs is their ability to recognize ubiquinated cargo at the 
endosome (Puertollano and Bonifacino, 2004). This demonstrates that GGAs may act 
independently of AP1 in endosomal sorting of ubiquitinated cargo.  
 
Cargo in membrane traffic 
 
As mentioned previously, membrane traffic occurs between various organelles and 
compartments. Therefore extensive sorting occurs at the site of emanating vesicles, 
since vesicles need to contain not only cargo but also factors required for the 
subsequent fusion (Bonifacino and Rojas, 2006; Maxfield and McGraw, 2004). Fusion 
specificity and the recognition of correct target membranes by vesicles is as complex as 
the initial sorting (Pfeffer, 2007). However, one commonly used approach to distinguish 
between individual transport routes is to characterize the cargo being transported. Using 
this approach, proteins that influence specific cargoes can be located in specific 
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transport routes. Model cargoes include transferrin-receptor (TfrR), epidermal growth 
factor receptor (EGFR) and Shiga-toxin subunit B (STxB) at the plasma membrane, as 
well as TGN46 and mannose-6-phosphate receptors (M6PR) emanating from the TGN. 
All of these cargoes traffic via endosomes and use distinct sets of proteins for their 
correct transport. CHC17 has been demonstrated to be part of individual sorting steps 
for all of the mentioned cargoes, except TGN46. TfrR and EGFR are internalized from 
the plasma membrane by means of CHC17-mediated endocytosis and subsequently 
recycled to the plasma membrane  (TfrR) or degraded in the lysosome (EGFR). STxB is 
internalized in a clathrin-independent manner, however its endosomal sorting requires 
CHC17 (Saint-Pol et al., 2004). Although it has been demonstrated that TGN46 cycles 
between endosomes and TGN (unlike its murine counterpart TGN38, which also cycles 
via the plasma membrane) (Banting et al., 1998), very few proteins associated with its 
trafficking are known, one of them being Syntaxin 6 (Ganley et al., 2008). M6PR in 
contrast has been extensively studied as a receptor for hydrolases destined for 
lysosomes (Ghosh et al., 2003a). M6PR exit from the TGN and possibly also its sorting 
at the endosome is CHC17-dependent. There is some debate in the literature, however, 
regarding the nature of the endosomal compartment from which M6PR retrograde 
sorting is accomplished (Ganley et al., 2008; Rojas et al., 2007). It remains to be seen 
whether M6PR return to the TGN via early or late endosomes. Taken together, these 
model cargoes offer a toolbox with which individual trafficking routes can be 
distinguished, even though CHC17, possibly using distinct sets of adaptors, may be 
involved in multiple sorting steps.   
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Clathrin heavy chains 
 
While much has been learned about the biology of CHC17 since its initial description 
(Pearse, 1976), the second isoform of clathrin heavy chain in humans remains largely a 
mystery. The encoding gene, CLTCL1 (old name: CLTD), was described by several 
groups over 10 years ago (Kedra et al., 1996; Long et al., 1996; Sirotkin et al., 1996). 
Expression of encoding RNA was found at low levels in all tissues with increased 
expression in testis and heart muscle. The highest expression levels were seen in 
skeletal muscle. The encoded protein has also been detected in a variety of cell lines 
and tissues (Liu et al., 2001; Towler et al., 2004a). Subsequent analysis and 
comparisons of the two clathrin heavy chain genes revealed that they are highly 
homologous, the resulting proteins showing 85% amino acid identity (Wakeham et al., 
2005). The two clathrin heavy chains were separated during a gene dublication event 
that occurred 510-600 million years ago. This study also revealed that CHC22, while 
present in most vertebrates, is absent from mice. Instead, a pseudogene was discovered 
in the mouse genome indicating that mice lost the CLTCL1 gene later in evolution. 
Divergence analysis indicated that there are only 12 amino acid changes, that are 
evolutionarily conserved between the two clathrin heavy chain genes (Wakeham et al., 
2005). Suspiciously, they are concentrated in the n-terminal domain required for adaptor 
protein interaction and the proximal leg domain required for binding CLCs. Indeed, 
previous work indicated that CHC22 does not bind CLCs in cells and it further differs 
from CHC17 by not binding the endocytic adaptor protein AP2 (Liu et al., 2001). 
However, CHC22 does bind the adaptor proteins AP1 and AP3, localizing CHC22 
function in the vicinity of TGN and endosomes. To date, only one protein has been 
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described that interacts with CHC22 but not CHC17. The sorting nexin family member 
SNX5 binds CHC22 in the proximal leg domain. Interestingly, this is the same region that 
is occupied on the CHC17 molecule by CLCs (Towler et al., 2004a). An important 
characteristic of CHC22 is its high expression in skeletal muscle. Indeed, in contrast to 
CHC17, CHC22 is upregulated during muscle differentiation, suggesting that it could play 
a specialized role in muscle biology (Liu et al., 2001).  
 
Skeletal muscle differentiation 
 
Skeletal muscle is a highly specialized tissue with the principal function of generating 
movement. Its regular cellular functions are highly specialized and adapted to serve this 
purpose. Mature muscle is generated in a complicated differentiation process 
encompassing several characteristic steps (Le Grand and Rudnicki, 2007) (Fig. 1-3). 
 
 
 
 
 
 
 
 
 
I will briefly discuss muscle differentiation with an emphasis on membrane 
compartments (Towler et al., 2004b). Precursor cells to mature musclefibers are 
 
A
  
B
  
C
  
Fig. 1-3: Skeletal muscle differentiation: (A): mononucleated precursor myoblasts with 
regular Golgi localization. (B) multinucleated myotubes with centrally located nuclei surrounded 
by Golgi membranes. (C) multinucleated myofibers with nuclei and Golgi membranes located in 
close proximity to the plasma membrane. Also, Golgi membranes are found in the core of fibers 
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mononucleated myoblasts that display regular Golgi morphology (Fig. 1-3A). Upon 
differentiation myoblasts fuse and elongate to form myotubes (Fig. 1-3B). Golgi 
membranes show a very characteristic localization in these cells as they are surrounding 
myonuclei. Interestingly, centrosomal markers such as pericentrin and -tubulin are also 
found surrounding nuclei (Bugnard et al., 2005). Further maturation of myotubes leads to 
establishment of the contractile apparatus. In this process membranes and nuclei are 
relocated in close proximity of the plasma membrane, resulting in the formation of 
mature myofibers (Fig. 1-3C). Myofibers exhibit specialized membrane domains such as 
T-tubules and myotendinous and neuromuscular junctions connecting fibers with other 
fibers and neurons respectively. Furthermore myotubes and myofibers exhibit 
specialized membrane pathways and compartments supporting their physiological 
function. One such compartment is the GLUT4 storage compartment. 
 
The GLUT4 storage compartment 
 
Skeletal muscle generates movement. This requires large amounts of energy that 
muscle takes up from the blood stream in the form of glucose. All tissues including 
skeletal muscle express glucose transporters for constitutive glucose uptake at their 
surface. However, skeletal muscle and adipose tissue have developed a second, 
inducible system in addition to the ubiquitous uptake of glucose from the bloodstream. In 
skeletal muscle this regulated glucose-uptake system is activated under conditions of 
high glucose levels in the bloodstream, indicated by increased insulin levels, or under 
conditions of high glucose requirement in the muscle, namely exercise. The system 
works by increasing the number of glucose transporter molecules on the cell surface. 
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The glucose transporter that is inducible in this way is isoform GLUT4, and the 
compartment from where GLUT4 is translocated to the plasma membrane is termed 
GLUT4 storage compartment (GSC). Failures in this system have been implicated in 
type II diabetes (Bryant et al., 2002; Huang and Czech, 2007). 
The GSC is a specialized compartment storing GLUT4 under basal conditions (Fig 1-4). 
 
 
 
 
 
Under basal conditions, characterized by low blood glucose and hence low insulin levels, 
the rate of GLUT4 endocytosis and sorting into the GSC is high. Upon activation of the 
GSC by means of exercise or high blood glucose levels resulting in increased insulin 
levels, a reversal in the rates of GLUT4 endo- and exocytosis is induced. This results in 
translocation of GLUT4 to the plasma membrane, where an increased amount of 
glucose transporters leads to increased glucose influx.  
The molecular mechanism underlying this complex system and possible involvement of 
clathrin heavy chains are only beginning to be unveiled. CHC17 has been demonstrated 
to at least partially mediate GLUT4 endocytosis and recycling back to the plasma 
Fig. 1-4: The GLUT4 storage compartment: left: GLUT4 accumulation in the GSC under basal 
conditions. Note the high rates of GLUT4 endocytosis and sorting into the GSC depicted by thick 
arrows. Right: upon insulin activation a reversal in the rates of endo- and exocytosis occurs 
resulting in net accumulation of GLUT4 at the plasma membrane 
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membrane from endosomal membranes (Antonescu et al., 2008; Huang et al., 2007; Li 
et al., 2007). In addition, members of the GGA-family of monomeric clathrin adaptors 
have been implicated in exporting newly synthesized GLUT4 from the TGN and possibly 
the endosome, although data is conflicting in this regard. (Li and Kandror, 2005; Watson 
et al., 2004; Watson and Pessin, 2008). Several other proteins have been identified that 
play roles in the generation and function of the GSC as well as trafficking of GLUT4, 
among them the SNARE-proteins VAMP2 and Syntaxin 6 (Williams and Pessin, 2008). 
Notably, the vast majority of this data was gathered in an adipocyte cell line generated 
from mice (3T3-L1). Importantly, fundamental differences have been described in 
glucose homeostasis between mice and humans. Generally, blood glucose levels are 
controlled to a much higher degree by the release of glucose from the liver in mice, 
whereas humans control their blood glucose levels primarily through the regulated 
uptake of glucose from the bloodstream by skeletal muscle as described here (Bruning 
et al., 1998; Michael et al., 2000).  
 
Aim 
 
The overall aim of this work is to establish the function of CHC22. To this end 
comparative studies between CHC17 and CHC22 are carried out concentrating on cell 
culture approaches. Model systems include the epithelial-derived cell line HeLa for 
analysis of ubiquitous CHC22 functions and the human skeletal muscle cell line 
LHCNM2 for analysis of CHC22 in this specialized cell type exhibiting highest levels of 
CHC22 expression.  
The studies that will be described show a role for CHC22 independent of CHC17 in 
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endosomal sorting. One cargo depending on CHC22 is characterized in GLUT4. 
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Chapter 2 - Distinct functions for clathrin heavy chain isoforms in 
endosomal sorting 
 
The text of this chapter is a manuscript in preparation. Some additional data will be 
incorporated pending outcome of experiments as discussed at the end of the chapter. 
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Abstract 
 
The ubiquitious clathrin heavy chain, CHC17, is well characterized as a vesicle coat 
component and has recently been implicated in Golgi biogenesis and mitosis.  The 85% 
sequence identity between CHC17 and its isoform CHC22 does not predict the extent to 
which CHC22 shares CHC17 functions. The comparative intracellular roles of the two 
clathrin heavy chains were analyzed in HeLa. CHC22 was not recruited to the mitotic 
spindle nor did its depletion affect endocytosis, demonstrating that these are unique 
functions of CHC17. However, upon siRNA depletion of CHC17, CHC22 showed 
increased membrane association and depletion of either CHC resulted in distinct 
trafficking defects of various cargoes between endosome and TGN. Depletion of both 
clathrin heavy chains had a more pronounced effect on Golgi compartments than 
depletion of CHC17 alone, indicating that Golgi biogenesis is influenced by the distinct 
trafficking pathways of both clathrins. In differentiated human myoblast cultures, similar 
segregation of CHC functions was detected, revealing the endosome-TGN transport as 
the pathway in which CHC22 exerts its muscle-specific function. 
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Introduction 
 
Clathrin heavy chain 17 (CHC17) is well characterized as a coat protein required for 
vesicle formation at the plasma membrane, the trans-Golgi network and endosomes 
(Brodsky et al., 2001; Conner and Schmid, 2003). Most vertebrates and mammals have 
a second clathrin heavy chain isoform (CHC22; names are designated in accordance 
with the genes position on human chromosomes) with mus musculus being the notable 
exception having only a pseudogene (Wakeham et al., 2005). CHC22 exhibits limited 
expression in all tissues with high expression in cardiac and skeletal muscle (Sirotkin et 
al., 1996). Comparisons between CHC17 and CHC22 show 85% amino acid identity, 
with amino acid changes occurring throughout the whole gene. Interestingly however, 
several amino acid changes, predominantly in the n-terminal domain and the proximal 
leg domain, are evolutionarily conserved, indicating that they are functionally relevant 
(Wakeham et al., 2005).  
 
CHC17 forms trimers, so-called triskelia that serve as the functional unit to assemble into 
flat lattices on membranes and eventually coats on vesicles. It has been demonstrated 
that vesicle formation requires CHC17 for invaginating the membrane (Hinrichsen et al., 
2006). CHC17 binds clathrin light chains (CLC) that act in a regulatory fashion on coat 
formation (Liu et al., 1995), although recent data suggest CLC are not essential in this 
process (Poupon et al., 2008). CHC17 is recruited onto membranes by adaptor proteins 
that bind to cargo destined for trafficking. Also, there are several accessory proteins 
required for cargo selection. The interplay between these factors determines the fate of 
the cargo (Benmerah and Lamaze, 2007; Ungewickell and Hinrichsen, 2007). Recently 
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CHC17 has been shown to be required in additional processes, namely spindle 
formation in mitosis (Royle et al., 2005), and Golgi reassembly after drug-induced 
fragmentation (Radulescu et al., 2007). Depletion of CHC17 leads to malformation of the 
mitotic spindle and incomplete stack separation within the Golgi.  
 
We previously demonstrated that CHC22 forms trimers but it does not stably associate 
with CLC.  Also, CHC22 does not bind the adaptor protein AP2 – the main regulator of 
clathrin-mediated endocytosis at the plasma membrane. However, it has been shown 
that CHC22 can associate with the adaptor proteins AP1 and AP3, which are localized at 
the TGN and endosomes, suggesting a role in transport processes in these 
compartments. A unique interaction partner of CHC22 has been found in sorting nexin 5 
(Liu et al., 2001; Towler et al., 2004a). Sorting nexin 5 has been implicated in 
macropinocytosis and may act as part of the retromer complex (Kerr et al., 2006; 
Wassmer et al., 2007). Still, a pathway for CHC22 function has yet to be defined. 
 
Early endosomal sorting is a complex process, as numerous cargo molecules have to be 
destined for a variety of targets (Bonifacino and Rojas, 2006; Maxfield and McGraw, 
2004). Several cargo molecules have been shown to traffic at least partly through the 
early endosome en route from and to other destinations within the cell and they serve as 
markers for distinct trafficking routes. Cargoes that are sorted at the endosome upon 
arrival from the plasma membrane include the transferrin receptor (Harding et al., 1983), 
which is recycled back to the plasma membrane, Shiga-Toxin, which traverses the 
endosome en route to the TGN and subsequently the endoplasmatic reticulum (Mallard 
et al., 1998) and EGF, which upon endocytosis is trafficked via the early endosome to 
lysosomes for degradation (Hanover et al., 1984). Cargoes arriving from the TGN 
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include mannose-6-phosphate receptors (M6PR) and TGN46 both of which are 
ultimately recycled to the TGN (Banting et al., 1998; Geuze et al., 1985). However, while 
TGN46 is thought to recycle back to the TGN directly from early endosomes, a 
significant portion of M6PR is trafficking via the late endosome (Ganley et al., 2008). 
Elucidating CHC17s role in these sorting events has been complicated by the fact that 
at least some of these cargoes also require CHC17 for trafficking from their respective 
origins.   
 
Here we compare properties of the two clathrin heavy chain isoforms using siRNA-
mediated depletion. We show that CHC22 does not act together with CHC17 but instead 
has an independent role in sorting specific cargo at the early endosome. Both clathrin 
heavy chains contribute to Golgi morphogenesis by means of their independent 
functions. 
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Results 
 
CHC22 associates with peripheral membranes but does not partake in CHC17 
function 
 
We were interested in the relationship between the two clathrin heavy chains CHC17 
and CHC22. While the ubiquitous CHC17 is well characterized, very little is known about 
its homologue CHC22. Polyclonal antibodies against CHC22 were raised in rabbits 
against the trimerization domain of CHC22 (aa 1521-1640) as well as a peptide (aa 
1549-1563). Both antibodies were purified to recognize CHC22 but not CHC17 and gave 
identical results in subsequent studies. Immunofluorescence analysis revealed a number 
of vesicles carrying CHC22 scattered throughout the cytoplasm, with a slight focus in the 
perinuclear area (Fig. 2-1). Some of these vesicles also seemed to carry CHC17 
although very little direct colocalization was observed (Fig. 2-1a). 
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The intracellular distribution of endogenous CHC22 was further characterized regarding 
known cellular markers for various organelles. Previous results indicated that CHC22 
does not associate biochemically with either CHC17, clathrin light chains or the clathrin 
adaptor protein AP-2 directly, however, it co-immunoprecipitates with the clathrin adaptor 
proteins AP-1 and AP-3. Also, overexpressed CHC22 partially colocalized with both AP-
Figure 2-1: CHC22 colocalizes partially with late endosomes but not early endosomes 
or the TGN: HeLa cells were grown on coverslips, processed for immunofluorescence and 
stained using a polyclonal antibody against CHC22 (right row, red in merge). Simultaneous 
staining were performed using monoclonal antibodies (left row, green in merge) against 
CHC17 (A), EEAI (B), SNX1 (C), -adaptin (D) GGA2 (E), AP3 (G), Rab9 (F) and a sheep 
polyclonal antibody against TGN46 (E). 
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1 and AP-3 (Liu et al., 2001). This suggested that CHC22 acts in the TGN and early 
endosomes. Contrary to this hypothesis, at steady state endogenous CHC22 does not 
colocalize with the early endosome as indicated by costaining with EEAI (Fig. 2-1b) or 
SNX1-positive transport vesicles (Fig. 2-1c). Neither does it seem to be accumulated in a 
significant manner at the TGN as marked by the clathrin adaptors AP1 (Fig. 2-1d) and 
GGA2 (Fig. 2-1e) or TGN46 (Fig. 2-1f). However, some colocalization along with a 
related staining pattern for CHC22 was observed with AP3 (Fig. 2-1g) and Rab9 (Fig. 2-
1h), a marker for the late endosome (Lombardi et al., 1993). In contrast, CHC17 does 
not colocalize with Rab9 (data not shown). This data suggests that CHC22 is 
concentrated on vesicular membrane structures, some of which also carry at least 
partially CHC17, AP3 and Rab9.   
 
We used siRNA-mediated depletion of clathrin heavy chains to gain further insight into 
their relationship and potential differing functions. Transfecting siRNAs specific for either 
clathrin heavy chain resulted in strong downregulation of the respective targets. (Fig. 2-
2a). Interestingly, CHC22 was stabilized in CHC17-KD cells, while the reverse was not 
true. Also, stabilities of clathrin light chains were monitored. CHC17 is required for CLC 
stability, while CHC22 is not, in accordance with earlier data that CLC do not bind 
CHC22 (Liu et al., 2001).  Preparations of heavy and light membrane fractions as well as 
a cytosolic fraction from cells treated with siRNA against CHC17 revealed that in these 
cells CHC22 is accumulated on light membranes as CHC22-levels in these fractions 
increase while CHC22-levels in the cytosol are decreased (Fig. 2-2b). This argues for a  
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Figure 2-2: CHC17 downregulation leads to stabilization of CHC22 on membranes but not 
on mitotic spindles. (A) HeLa cells were treated with control siRNA or siRNA against CHC17, 
CHC22 and CHC17 together with CHC22 as described in material and methods. Whole cell 
lysates were prepared, separated in SDS-PAGE and transferred onto nitrocellulose membrane. 
Membranes were probed with the indicated antibodies. -actin serves as a loading control. (B) 
HeLa cells were treated with either control siRNA or siRNA against CHC17. Whole cell lysates 
were fractionated in a nuclear fraction (P1, 3000 x g), a membrane fraction (100.000 x g) and a 
soluble fraction (S) and analyzed in immunoblotting with the indicated antibodies. (C) HeLa cells 
treated with siRNA as indicated were processed for immunofluorescence and stained for CHC17 
and CHC22. (D) WT HeLa cells were processed for immunofluorescence. Mitotic cells were 
imaged as determined by condensed chromatin. (E) Experiment as in D using HeLa cells 
depleted of CHC17 using specific siRNA. (F) Experiment as in D using HeLa cells expressing 
full-length CHC22 under the control of inducible T7 promotor. (G) Experiment as in D using 
HeLa cells expressing CHC22-Hub fragment under the control of inducible T7 promotor. 
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stabilization of CHC22 in cells depleted of CHC17 due to increased membrane 
association. Interestingly, even in control cells the ratio of membrane-bound to soluble 
CHC22 is higher than for CHC17. Similar results were obtained in immunofluorescence 
experiments (Fig. 2-2c). We note an accumulation of CHC22 in the perinuclear area in 
CHC17-depleted cells when compared to control transfected cells. Vice versa, CHC17 is 
not affected by depletion of CHC22 either in membrane association (data not shown) or 
immunofluorescence (Fig. 2-2c). Recently an additional function of CHC17 has been 
revealed in spindle assembly of mitotic cells (Royle et al., 2005). In contrast to CHC17, 
CHC22 was not found on spindles in mitotic cells (Fig. 2-2d). Depletion of CHC17 did not 
lead to spindle recruitment of CHC22 either (Fig. 2-2e). Furthermore, overexpressing a 
T7-CHC22 full-length construct (Liu et al., 2001) in an attempt to force CHC22 onto 
spindles resulted in a similar distribution as a c-terminal T7-CHC22-Hub construct (aa 
1074-1640) (Fig. 2-2f, g). This construct was used as a control, as the corresponding 
CHC17-fragment cannot be recruited to the spindle, due to the lack of the n-terminal 
domain despite its ability to trimerize (Royle et al., 2005). These results indicate that 
CHC22 does not partake in spindle association as CHC17 does. A notable difference in 
CHC22-decorated membranes and Golgi membranes coated by CHC17 was the 
sensitivity to Brefeldin A (BFA), a drug that inhibits Golgi-formation (Lippincott-Schwartz 
et al., 1989). Whereas CHC17 staining is perturbed in the perinuclear area in cells 
treated with BFA, CHC22-staining appears normal, indicating that CHC22 recruitment is 
Arf1-independent (Fig. 2-3a). Also, clathrin-mediated endocytosis of transferrin-receptor, 
which is strongly inhibited in CHC17-depleted cells (Hinrichsen et al., 2003), (Motley et 
al., 2003) is not affected in CHC22-depleted cells (Fig. 2-3b). This finding is consistent 
with CHC22 not binding AP-2, the main adaptor protein required for receptor-mediated 
endocytosis.  
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Figure 2-3: BFA-treatment does not prevent CHC22 membrane association and depletion 
of CHC22 does not affect endocytosis. HeLa cells were depleted of CHC17 and CHC22 using 
specific siRNAs as indicated, incubated in the presence of BFA for 45 min., processed for 
immunofluorescence and stained using antibodies against CHC22 and GM130 as indicated. 
GM130 served as an internal control for Golgi fragmentation. (B) HeLa cells were grown on 
coverslips and transfected with combinations of fluorescence-labelled control siRNA and siRNA 
targeting CHC22 or siRNAs targeting CHC17 and CHC22. Cells were incubated with fluorescent 
transferrin as described in material and methods and internalization was allowed for 20 min. Cells 
were then fixed and processed for immunofluorescence using the indicated markers. 
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Taken together, we found no evidence for CHC22 acting together with or substituting for 
CHC17.  
 
CHC17 and CHC22 act independently in endosomal sorting 
 
We previously showed that overexpression of a c-terminal T7-CHC22-Hub construct (aa 
1074-1640) affects mannose-6-phosphate receptor localization in that it is dispersed 
from its normal perinuclear focus throughout the cell (Liu et al., 2001). Overexpression of 
either a T7-CHC22 full-length construct (Liu et al., 2001)  or a n-terminal GFP-CHC22-
TD construct (aa 1-450, data not shown) did not have the same effect. Interestingly the 
corresponding CHC17-Hub fragment has an inhibitory effect on receptor-mediated 
endocytosis, acting as a dominant-negative mutant in this process (Bennett et al., 2001; 
Liu et al., 1998). Therefore we assessed the roles of clathrin heavy chains in M6PR-
trafficking in cells depleted of clathrin heavy chains. M6PRs are exported from the TGN, 
where they bind hydrolases destined for the lysosome, in a CHC17 and AP-1 dependent 
manner (Meyer et al., 2000). Whereas M6PR was localized loosely in the perinuclear 
area in control cells, CHC17-depletion lead to a very tight perinuclear localization of 
M6PR, presumably the TGN (Fig. 2-4a). This is consistent with previous data 
(Hinrichsen et al., 2003). In contrast, depletion of CHC22 led to a different phenotype in 
that M6PR was dispersed throughout the cytosol in small vesicular structures (Fig. 2-4a). 
We note that membranes carrying M6PR in CHC22-depleted cells do not carry CHC17. 
To test whether the redistribution of M6PR in cells depleted of either clathrin heavy chain 
had effects on M6PR-function we measured the secretion of the lysosomal hydrolase  
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Figure 2-4: CHC17 and CHC22 affect CI-MPR- and TGN46 function in differential ways. (A) 
HeLa cells were depleted of CHC17 and CHC22 using specific siRNAs as indicated, processed 
for immunofluorescence and stained using antibodies against CHC17 and CI-MPR as indicated. 
(B) HeLa cells were treated with indicated siRNAs and intra- and extracellular Hexosaminidase 
activity was measured as described in material and methods. Depicted are ratios of extracellular 
to intracellular Hexosaminidase activities normalized against control ratios (n=5). (C) HeLa cells 
were depleted of CHC17 and CHC22 using specific siRNAs as indicated, processed for 
immunofluorescence and stained using antibodies against CHC17 and TGN46 as indicated. 
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hexosaminidase (Fig. 2-4b) Newly synthesized hexosaminidase is trafficked to the 
lysosomes by means of M6PR. Impairment of this pathway leads to increased secretion 
of hexosaminidase due to missorting at the TGN (Riederer et al., 1994). Secreted 
hexosaminidase-levels were measured in CHC17- and CHC22-depleted cells and 
normalized to control levels. Cells depleted of CHC17 exhibited a 70% increase in 
secreted hexosaminidase, while CHC22-depleted cells exhibited a 22% increase. 
Therefore the effect of CHC17-depletion was much stronger than the effect of CHC22-
depletion, however both were statistically significant. Interestingly, in cells treated with 
siRNA against both CHC17 and CHC22 secreted hexosaminidase increased by 90% 
suggesting additional effects of depleting both clathrin heavy chains, although the 
difference between CHC17- and CHC17 + CHC22-depleted cells was not statistically 
significant in this set of experiments. The vesicular staining pattern of M6PR in CHC22-
depleted cells was reminiscent of endosomal staining. To test the possibility of M6PR 
being retained in early endosomes, we costained clathrin heavy chain depleted cells for 
M6PR and the early endosome antigen I (EEAI). It has been reported that M6PR localize 
to early endosomes in cells depleted of retromer, a protein complex required for M6PR-
trafficking out of early endosomes (Arighi et al., 2004), (Seaman, 2005). Therefore we 
used depletion of the retromer-subunit sorting nexin 1 (SNX1) as a control. In CHC17-
depleted cells EEAI-localization seemed shifted from its normal staining pattern 
throughout the cell towards a perinuclear localization (Fig. 2-5). This, again, is in 
accordance with previous observations (Hinrichsen et al., 2003). CHC22-depleted cells, 
however, showed little overall change in EEAI localization, although we frequently noted 
extended, tubular structures. Importantly, M6PR did not colocalize with EEAI, despite a 
similar staining pattern, implying that M6PR is retained in a compartment other than the 
early endosome. In contrast, SNX1-depleted cells showed colocalization of M6PR and  
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Figure 2-5: M6PR is not retained in early endosomes in cells depleted of CHC22. HeLa cells 
were depleted of CHC17, CHC22 and SNX1 using specific siRNAs as indicated, processed for 
immunofluorescence and stained using antibodies against EEAI and CI-MPR as indicated. 
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EEAI mirroring literature data (Seaman, 2004). This data indicates that both CHC17 and 
CHC22 are implicated in the trafficking of M6PR acting at different steps in M6PR 
cycling. Also, CHC17 and CHC22 may not compensate their respective roles for one 
another. 
 
To compare the findings on M6PR-trafficking with other molecules that traffic between 
the TGN and endosomes we assessed TGN46 in clathrin heavy chain depleted cells. 
Differences in M6PR and TGN46 transport have recently been exploited to distinguish 
retrograde pathways from the endosome to the TGN (Ganley et al., 2008). TGN46 
cycles between the TGN and the early endosome with the vast majority being localized 
to the TGN at steady state. However, unlike its rodent homologue TGN38, TGN46 does 
not traffic via the plasma membrane (Banting et al., 1998). Immunofluorescent analysis 
of TGN46 in control cells showed strong perinuclear staining indicative of the TGN-
localized pool of TGN46 (Fig. 2-4c). In contrast, CHC17-depletion leads to a dispersal of 
TGN46 throughout the cytoplasm. Also, the fluorescent intensity appeared diminished 
when compared to control cells. This effect seemed to be CHC17-specific, since cells 
depleted of CHC22 exhibited normal TGN46 localization. Immunoblotting of lysates from 
siRNA-treated cell revealed that TGN46-levels were drastically reduced in CHC17-
depleted cells, matching immunofluorescence (data not shown). CHC22-depleted cells 
contained TGN46-levels resembling control levels. This demonstrates that unlike M6PR, 
TGN46 trafficking is independent of CHC22.  
 
Since both TGN46 and M6PR cycle between TGN and endosomes, it is difficult to 
assess the potential roles clathrin heavy chains play in trafficking cargo from both 
compartments. Therefore we used Shiga-Toxin B (STxB) as a cargo probe since its 
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trafficking is unidirectional (Mallard et al., 1998). Upon clathrin–independent entry into 
cells, STxB is trafficked via EEAI-positive early endosomes in a CHC17- and retromer-
dependent step to the TGN (Bujny et al., 2007; Saint-Pol et al., 2004). Interestingly, it 
has been proposed that CHC17 and retromer act in a sequential manner, although both 
are required for exit of STxB from the early endosome with CHC17 coating defining 
microdomains, which are subsequently tubulated by retromer (Popoff et al., 2007). We 
tested the transport of STxB in cells depleted of clathrin heavy chains. After internalizing 
for 15 min in control cells or cells depleted of either clathrin heavy chain, STxB was 
found to colocalize with EEA (Fig. 2-7) and after 60 minutes STxB showed Golgi-
localization in control cells (Fig. 2-6), resembling described kinetics (Saint-Pol et al., 
2004). In contrast, CHC17-depleted cells showed STxB to be dispersed and colocalized 
with EEAI (Fig. 2-6, Fig. 2-7), even after 60 minutes of internalization again mirroring 
published data (Saint-Pol et al., 2004). To our surprise, under the same uptake-
conditions CHC22-depleted cells also exhibited dispersed STxB-staining (Fig. 2-6). 
Importantly though, in case of CHC22-depleted cells, STxB was not colocalized with 
EEAI-positive structures (Fig. 2-7) suggesting that STxB is retained in a post- early 
endosome compartment, since STxB trafficks through an EEAI-positive compartment 
after 15 min. of internalization. 
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Figure 2-6: CHC17, CHC22 and SNX1 affect Shiga-toxin trafficking: HeLa cells were 
depleted of CHC17, CHC22 and SNX1 using specific siRNAs as indicated. Fluorescent Shiga-
toxin in fresh media was bound to cells for 30 min on ice, washed in PBS and chased for 60 
min. in fresh media at 37C. Cells were fixed, processed for immunofluorescence and stained 
using an antibody against CHC22.  
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Figure 2-7: STxB retrograde trafficking is impaired in CHC17, CHC22 and SNX1-
depleted cells: (A) HeLa cells were depleted of CHC17, CHC22 and SNX1 using specific 
siRNAs as indicated. Fluorescent Shiga-toxin in fresh media was bound to cells for 30 min on 
ice, washed in PBS and chased for 15 or 45 min. in fresh media at 37C. Cells were fixed, 
processed for immunofluorescence and stained using antibodies against CHC22 and EEAI as 
indicated.  
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Since both M6PR and STxB have been reported to be retromer-dependent in their exit 
from the early endosome, we assessed whether they traffic together in a clathrin heavy 
chain dependent way. Staining simultaneously for EEAI and M6PR in cells undergoing 
STxB internalization, showed that all three markers accumulate in the same structures in 
CHC17- and to some extend in SNX1-depleted cells (Fig. 2-7). In contrast, both M6PR 
and STxB are trafficked away from EEAI-positive early endosomes and accumulate 
together in downstream vesicles in CHC22-depleted cells. Together this data suggest a 
role for CHC22 in trafficking from early endosomes, downstream of both CHC17 and 
retromer function. Interestingly, pathways for M6PR and STxB must diverge even further 
downstream of CHC22-function, since M6PR is thought to traffic to late endosomes, 
while STxB traffics straight to the TGN (Ganley et al., 2008).  
 
We tested the effect of clathrin heavy chain depletion on the late endosome using the 
GTPase Rab9 as a marker (Lombardi et al., 1993) as we were interested in a 
compartment potentially depending on membrane flow from upstream trafficking events 
involving clathrin heavy chains. Rab9 is recruited selectively onto late endosomes and is 
required for transport of M6PR from late endosomes to the TGN. Loss of Rab9 leads to 
a reduction in size and number of late endosomes. Also, their localization is shifted to a 
perinuclear position (Ganley et al., 2004). CHC17-depleted cells showed no obvious 
defect in Rab9 localization when compared to control cells (Fig. 2-8). In contrast, cells 
depleted of CHC22 showed Rab9-positive membranes much more tightly associated 
with the nucleus (Fig. 2-8). This result emphasizes the importance of CHC22 for correct 
late endosome generation. 
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Both CHC17 and CHC22 contribute to Golgi morphogenesis 
 
CHC17 has recently been implicated in reassembly of the Golgi apparatus after drug-
induced fragmentation (Radulescu et al., 2007). Golgi fragments containing Cis- and 
medial-marker proteins did not separate correctly in CHC17-depleted cells recovering 
from Brefeldin A or butanol treatment. This finding was attributed to a lack of unmixing of 
membranes resulting in a “tight” phenotype. A similar situation of a fragmented Golgi 
followed by reassembly, occurs in cell division as Golgi membranes are redistributed 
throughout the mitotic cell and reassembled in cytokinetic cells via so-called “Golgi twins” 
Figure 2-8: CHC22 but not CHC17 affects Rab9 localization: HeLa cells were depleted of 
CHC17 and CHC22 using specific siRNAs as indicated, processed for immunofluorescence 
and stained using antibodies against CHC22 and Rab9 as indicated.  
Chapter 2 – Distinct functions for clathrin heavy chain isoforms in endosomal sorting 
  
49 
(Colanzi and Corda, 2007; Gaietta et al., 2006). We probed cells depleted of CHC17, 
CHC22 or CHC17 and CHC22 for Golgi morphology using markers for the cis- and 
medial-Golgi compartment. We concentrated on cytokinetic cells as defined by still 
condensed chromatin. Golgi-twin formation was clearly visible in control cells (Fig. 2-9). 
While cells depleted of CHC22 alone did not exhibit an obvious phenotype (data not 
shown), cells depleted of CHC17 and even stronger CHC17 in combination with CHC22 
showed Golgi-fragmentation in cytokinetic cells. This is true for both cis- and medial- 
markers GM130 and GS27 (Fig. 2-9a, b). CHC17-depletion leads to some vesicles 
carrying the markers being localized away from the emerging Golgi, while the additional 
downregulation of CHC22 enhances this effect dramatically, resulting in Golgi 
membranes being dispersed throughout the whole cell.  
 
 
 
Figure 2-9: Mild and severe effect of CHC17- and CHC17+CHC22-depletion on Golgi 
morphology in cytokinetic cells: HeLa cells were depleted of CHC17 and CHC17 + CHC22 
using specific siRNAs as indicated, processed for immunofluorescence and stained using 
antibodies against CHC17 (A, green) and clathrin light chains (B, green) in combination with 
GM130 (A, red) and GS27 (B, red). Cytokinetic cells as determined by condensed chromatin 
and characteristic shape are identified by arrowheads. 
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One could expect this effect to last in interphase cells. However, only rarely did we 
detect dispersed GM130 and GS27-staining in interphase cells (Fig. 2-10). Also, a “tight” 
Golgi phenotype characteristic of mixed cis- and medial- Golgi stacks (Radulescu et al., 
2007) was rarely visible. Notably, the Golgi is not required to exhibit perfect stack 
separation to perform its function at moderate levels (Puthenveedu et al., 2006). 
 
 
 
 
CHC22 plays a similar role in endosomal sorting in human skeletal muscle 
 
Expression analyses in human tissue samples revealed that CHC22 is present at low 
levels in all tissues tested with moderate expression in testis and high expression in 
cardiac and skeletal muscle (Sirotkin et al., 1996). Skeletal muscle maintains a unique 
membrane system that is required for function of this specialized tissue. Several 
isoforms of ubiquitous trafficking molecules have been identified, that confer specific 
functions in skeletal muscle (Towler et al., 2004b). To confirm that the data generated in 
Figure 2-10: Golgi integrity is mildly affected in CHC17 and CHC17 + CHC22-depleted 
interphase cells. HeLa cells were depleted of CHC17 and CHC17 + CHC22 using specific 
siRNAs as indicated, processed for immunofluorescence and stained using antibodies against 
CHC17 (A, green) clathrin light chains (B, green) in combination with GM130 (A, red) and GS27 
(B, red). 
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HeLa also applies to tissues with high CHC22 expression, we analyzed clathrin heavy 
chains in a human skeletal muscle cell line. LHCNM2 cells are comparable in their 
growth and differentiation properties to the commonly used rodent cell lines C2C12 and 
L6 (Zhu et al., 2007). Immunofluorescence analysis of LHCNM2 depleted of clathrin 
heavy chains and differentiated to form myotubes revealed a similar phenotype for 
M6PR as in HeLa cells (Fig. 2-11a). Due to the Golgi being localized around myonuclei 
in skeletal myotubes, differences in M6PR-localization in CHC17-depleted cells is diffcult 
to score, but in CHC22-depleted cells a dispersal similar to the situation in HeLa is 
evident. Furthermore, we compared protein levels in CHC17- and CHC22-depleted cells 
(Fig 2-11b). CHC17-depletion resulted in increased CHC22-levels, while CHC17 was not 
significantly affected by CHC22-downregulation. We also monitored M6PR-levels (Fig. 2-
11b, c). Both CHC17- and CHC22-depletion lead to a decrease of total M6PR, to 83 % 
and 61 % of control cells respectively. Cathepsin D, a hydrolase trafficked to lysosomes 
by M6PR, matures proteolytically from a premature form leaving the TGN (53 kDa) and 
an intermediate form (47 kDa) into a mature form (31 kDa). Levels of the respective 
Cathepsin D forms may be used to assess trafficking towards the lysosome (Mardones 
et al., 2007). Interestingly, when compared to control cells, the ratio of pro- to mature 
forms of Cathepsin D in CHC17-depleted cells was not significantly altered (Fig. 2-11d). 
In CHC22-depleted cells however, there was a significant increase in the proforms of 
Cathepsin D, strongly arguing for a defect in its delivery to the lysosomes. 
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Figure 2-11: Specific effects of CHC17 and CHC22-downregulation on CI-MPR trafficking 
are observed in human skeletal muscle. (A) LHCNM2 human skeletal muscle myoblast were 
differentiated, depleted of CHC17 and CHC22 using specific siRNAs and processed for 
immunofluorescence. Cells were stained using antibodies against CI-MPR and GLUT4. (B) 
LHCNM2 cells were differentiated and depleted of CHC17 and CHC22. Whole cell lysates were 
prepared, separated in SDS-PAGE and transferred onto nitrocellulose membrane. Membranes 
were probed with the indicated antibodies. (C) quantification of CI-MPR levels in whole cell 
lysates generated as in (B). Shown are ratios compared to control (n=5). (D) quantification of 
Cathepsin D levels. Shown are ratios of precursor form to mature Cathepsin D relative to control 
(n=5).  
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Taken together this data shows that one of the key functions of CHC22 is required in 
skeletal muscle cells. Also, it confirms the operational localization in endosomes as 
defined in Hela cells for skeletal muscle cells.   
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Discussion 
 
In this study we compare the two clathrin heavy chain isoforms found in humans, CHC17 
and CHC22. While both isoforms share some key characteristics such as the ability to 
trimerize and the ability to partake in membrane trafficking events, we show that the less 
understood isoform CHC22 does not directly act together with CHC17 and may not 
substitute for CHC17 absence. Instead, CHC22 is involved in a discrete sorting step of 
M6PR and STxB at the early endosome. This function was observed in both epithelial 
and skeletal muscle cells.  
 
CHC22 not acting together with or substituting for the ubiquitous CHC17 is true for three 
known functions of CHC17, namely vesicle formation, spindle formation and Golgi stack 
separation. This is remarkable since CHC17 and CHC22 are highly homologous, 85% 
percent at the amino acid level (Wakeham et al., 2005). However, comparisons of amino 
acid changes across several species demonstrated that there are a number of amino 
acid changes that are evolutionary conserved, accumulated primarily in the n-terminal 
and proximal leg domain.  
 
The n-terminal domain of CHC17 mediates its interaction with adaptor proteins and 
indeed we previously showed, that CHC22 does not bind AP2, the main adaptor for 
endocytosis (Liu et al., 2001). Here we demonstrate that CHC22 does not partake in 
endocytosis, even in the absence of CHC17. Also, CHC22 may not rescue CHC17-
mediated export from the TGN of M6PR, which depends on adapting by AP1.  
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We also showed that CHC22 is not recruited to the spindle in mitotic cells, contrasting 
with the behaviour of CHC17 (Royle et al., 2005). Depletion of CHC17 or overexpression 
of CHC22, which was previously shown to result in recruitment of CHC22 onto the TGN 
(Liu et al., 2001), possibly by shifting binding affinities for AP1 and AP3, does not result 
in spindle recruitment either. In reverse, our data suggests that neither AP1 nor AP3 are 
involved in spindle recruitment of CHC17.   
 
A third role for CHC17 has been been demonstrated to be organizing cis- and medial-
Golgi stack formation after drug-induced fragmentation (Radulescu et al., 2007). We 
show that, while a subset of CHC17 bearing membranes presumably representing Golgi 
membranes are fragmented in BFA-treated cells, CHC22 staining seems normal, 
indicating that membrane association of CHC22 is Arf1-independent. Nonetheless, 
CHC22-depletion added to the severity of CHC17-depletion in a physiological situation in 
which Golgi assembly is required, cytokinesis. While we cannot rule out, that CHC22 
partially rescues CHC17-function in this process, we believe it to be unlikely, given 
CHC22s inability to rescue other functions of CHC17. Rather, we believe that a unique 
function of CHC22 in retrograde traffic from endosomes to the Golgi adds to the 
phenotype. This function is presumably to traffic Golgi proteins that have escaped the 
Golgi back to its origin. A similar mechanism of retrieval of escaped cargo has been 
demonstrated in ER to Golgi transport, where a balance of anterograde and retrograde 
traffic of escaped proteins results in concentration of proteins in their respective 
compartments (Appenzeller-Herzog and Hauri, 2006). 
Interestingly, mass spectrometric analyses of clathrin-coated vesicles identified CHC22 
being depleted from this fraction in CHC17 depleted cells suggesting that CHC22 may 
be associated with CHC17 on coated vesicles (Borner et al., 2006). However, based on 
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our findings we believe CHC22 is not associated with CHC17. Presumably, CHC22-
coated vesicles were copurified with CHC17-coated vesicles. We show in this study, that 
CHC22 acts downstream of CHC17 in endosomal sorting of M6PR and STxB. Hence, if 
trafficking of these cargoes is inhibited in CHC17-depleted cells, less CHC22-coated 
vesicles would be expected in the cell. Indeed we show that CHC22 is stabilized and 
potentially immobilized on membranes in CHC17-depleted cells.  
 
So, where does CHC22 function? Immunofluorescence showed, that most CHC22 
bearing structures did not carry CHC17, although some showed both CHC17 and 
CHC22 staining. CHC22 staining resembled endosomal staining, partly overlapping with 
AP3 and Rab9 but not EEAI. We note that despite considerable efforts we did not 
achieve immuno-electron microscopy with either antibody against CHC22. Therefore the 
exact morphology of CHC22 carrying vesicles is still unknown.  
 
Both clathrin heavy chains are required for M6PR trafficking. The function of CHC22 in 
this process is independent of CHC17 as staining patterns of M6PR in cells 
downregulated for either clathrin heavy chain were different. Also, downregulation of 
both CHC17 and CHC22 seemed to have an additive effect on secretion of 
hexosaminidase. CHC22-depletion led to a dispersed staining for M6PR, suggesting 
M6PR is trapped in an endosomal trafficking step.  
 
We used TGN46 as an alternative molecule cycling between TGN and endosomes. 
Recently, TGN46 has been used as a marker for retrograde trafficking from early 
endosomes to the TGN in comparison to M6PR-trafficking from the late endosome to the 
TGN (Ganley et al., 2008). We found that TGN46 trafficking does not depend on CHC22 
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at all, whereas it strongly depended on CHC17 for correct endosomal sorting. While it is 
difficult to rule out CHC17-mediated trafficking of TGN46 from the TGN, we find it 
unlikely, as M6PR accumulates in the TGN upon CHC17-depletion. Since CHC17 but 
not CHC22 affects TGN46 we interpret this finding as CHC17 and CHC22 being involved 
in discrete sorting steps at the endosome with CHC17 acting upstream of CHC22. 
  
We also used STxB as a marker molecule. One of the main advantages of STxB is its 
unidirectional trafficking pathway from the plasma membrane, via early endosomes to 
the TGN. CHC17 is only required for one sorting step of STxB at the early endosome 
(Mallard et al., 1998; Saint-Pol et al., 2004). Furthermore, it has recently been 
demonstrated that both M6PR and STxB are sorted by retromer at the early endosome 
(Arighi et al., 2004; Bujny et al., 2007; Popoff et al., 2007; Seaman, 2004). Surprisingly, 
we found that both CHC17 and CHC22-depletion result in a block of retrograde traffic of 
STxB from endosome to the TGN after 60 min of internalization. Interestingly though this 
block of STxB seemed to appear in different vesicles, as STxB-positive vesicles in 
CHC17-depleted cells were EEAI-positive, while STxB-positive vesicles in CHC22-
depleted cells were not. Of note, after 15 min. of internalization STxB was found in EEAI-
positive early endosomes in cells depleted of either clathrin heavy chain. This strongly 
argues that CHC22 acts downstream of CHC17 in endosomal sorting.  
 
It has previously been shown, that CHC17 and retromer act cooperatively in sorting of 
STxB (Popoff et al., 2007). It was proposed that while CHC17 concentrates STxB in 
microdomains within EEAI-positive endosomes and initiates membrane deformation, 
retromer may bind to deformed membranes and tubulate them. CHC17-dependent 
invagination of membrane has been demonstrated in case of the plasma membrane 
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(Hinrichsen et al., 2006). Subunits of retromer may include sorting nexin family members 
1,2,5 and 6 (Rojas et al., 2007; Wassmer et al., 2007), which include membrane 
curvature sensing BAR-domains (Carlton et al., 2004). Recently, the structure of 
retromer has been described (Hierro et al., 2007). Retromer leads to tubulation of 
membranes. However, it is unknown if these tubules connect early endosomes with the 
TGN directly or if they collapse and therefore form vesicles or both. So far, no reports on 
tubules directly connecting endosomes and TGN are available.   
 
We propose that CHC22 may traffic both M6PR and STxB in a novel sorting step after 
these cargoes have been sorted away from EEAI-positive early endosomes by CHC17 
and retromer (Fig. 7).  
 
 
 
CHC22 could be recruited to collapsing retromer-derived tubules via interaction with 
SNX5 (Towler et al., 2004a). CHC22 may act purely to stabilize membranes, but the fact 
Figure 2-12: model for CHC17 and CHC22 function in retrograde endosomal trafficking. 
Red indicates  mediators of membrane trafficking steps including  clathrin heavy chains, green 
indicates cargo molecules 
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that CHC22-depletion results in dispersed staining of M6PR and STxB suggests, that the 
CHC22 coated vesicles may not be processed further. CHC22 may be involved in further 
processing of these transport vesicles by recruiting factors required for downstream 
processing. Alternatively, CHC22 could sort proteins other than M6PR and STxB. We 
emphasize that although our model displays vesicular transport of cargo (Fig. 7), this is 
only to display functionally independent sorting events. Similar mechanism could apply 
to the endosomal model described by Bonifacino and Rojas, termed the “tubular 
endosomal network” in which the endosome is described as distinguishable domains, 
carrying differential sets of proteins, that are nonetheless connected (Bonifacino and 
Rojas, 2006). Of note, while STxB traffics directly from early endosomes to the TGN 
(Mallard et al., 1998), M6PR is thought to traffic via late endosomes (Lombardi et al., 
1993). That would require sorting of these cargoes into vesicles destined for the 
respective target membrane, molecular mechanism of which remain elusive. Further 
investigation will be required to solve this interesting problem.  
 
Lastly, we demonstrated that CHC22 acts in the same pathways in HeLa cells and 
human skeletal muscle. This is important, since CHC22 shows its highest expression in 
skeletal muscle and there are several specialized membrane pathways in muscle. 
Several isoforms of membrane trafficking proteins are found in skeletal muscle, that act 
in specialized ways in this tissue (Towler et al., 2004b). However, CHC22 is required for 
M6PR trafficking in skeletal muscle, indicating that its function is conserved in various 
tissues.  
 
In conclusion, we show in this work, that two clathrin heavy chain isoforms in human act 
independently from one another. Nonetheless, both are required for distinct cellular 
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functions, demonstrating how diversification of a common ancestor in evolution may lead 
to independent functions.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 – Distinct functions for clathrin heavy chain isoforms in endosomal sorting 
  
61 
Material and Methods 
 
Antibodies, recombinant proteins and siRNAs 
 
One monoclonal and one polyclonal antibody that specifically recognize CHC22 and not 
CHC17 have been described (Liu et al., 2001). A second polyclonal antibody against 
amino acids 1549-1563 from human CHC22 was raised by contract (New England 
Peptides). The antibody was purified negatively and positively, using recombinantly 
expressed trimerization domain fragments of human CHC17 and CHC22, respectively, 
coupled to NHS-Hi-Trap columns (Amersham) and specificity for CHC22 was confirmed 
by immunoblotting the recombinant fragments. Anti-CHC17 (mouse monoclonals X22 
and TD.1) and rabbit polyclonal against clathrin light chains) were generated in our 
laboratory (references available upon request). Commercial sources of antibodies were 
as follows: TGN46 (sheep polyclonal, Serotec), EEA1, AP1, SNX1, GM130 (mouse 
monoclonal, BD Transduction Laboratories), -actin (mouse monoclonal, Sigma), 
GM130 (rabbit polyclonal, Sigma), CI-MPR (mouse monoclonal, Calbiochem) Cathepsin 
D (rabbit polyclonal, Calbiochem). Monoclonal anti-GGA2 antibody was a gift from Juan 
Bonifacino (NIH, Bethesda) with permission from John Hopwood (Womens and 
Childrens Hospital, Adelaide), and monoclonal anti-Rab9 antibody was a gift from 
Suzanne Pfeffer (Stanford). Polyclonal anti-CI-MPR was a gift from Linton Traub 
(University of Pittsburgh). Secondary antibodies for immunofluorescence were from 
Molecular Probes (Alexa488, Alexa568, Alexa647 conjugates) and Jackson 
Immunoresearch (Cy3-conjugates). Secondary antibodies coupled to HRP were from 
Zymed Laboratories. 
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Recombinant Shiga-Toxin subunit B coupled to Cy3 was a gift from Ludger Johannes 
(Institute Pasteur, Paris). siRNAs were synthesized by Qiagen. DNA sequences targeted 
were AAGCAATGAGCTGTTTGAAGA for CHC17, AAGAACAAGACCAAGAGCCAC for 
SNX1 (Bujny et al., 2007) and TCGGGCAAATGTGCCAAGCAA and 
AACTGGGAGGATCTAGTTAAA for CHC22 (1:1 mixture of siRNAs were used).  
 
Cell culture, transfection, Brefeldin A treatment and STxB-internalization 
 
HeLa cells were grown in DMEM supplemented with 10% FBS, 50 U/ml penicillin, 50 
g/ml streptomycin and 0.625 g/ml fungizone. Tetracycline-inducible T7-CHC22-FL and 
T7-CHC22-Hub expressing HeLa cells were described previously (Liu et al., 2001). 
LHCNM2 human skeletal muscle cells (Zhu et al., 2007) were maintained in tissue 
culture flasks coated with rat-tail collagen in basal medium (4:1 DMEM:M199, 0.02 M 
HEPES, 0.03 g/ml ZnSO4, 1.4 g/ml Vitamin B12) with 10% fetal bovine serum (FBS), 
55 ng/ml dexamethasone, 2.5 ng/ml hepatocyte growth factor (Sigma), 50 U/ml penicillin, 
50 g/ml streptomycin, 0.625 g/ml fungizone (growth medium). Differentiation was 
induced by culturing in fusion medium (basal medium with 0.5 % FBS, 10 g/ml insulin, 
50 g/ml apo-transferrin and 5.5 ng/ml dexamethasone) followed by differentiation 
medium (basal medium with 0.5% FBS, 55 ng/ml dexamethasone).  
Cells were transfected with 0.8 μg/24-well expression vector using Lipofectamine 2000 
(Invitrogen) and assayed after 48 h following a 24 h period in the presence of 50 ng/ml 
tetracycline. Cells were transfected with 10 nM siRNA using HiPerfect (Qiagen) 
according to the manufacturers instructions. HeLa cells were split, reseeded 24 h post 
transfection and retreated with siRNA 24 h later. Cells were used for experimentation 72 
h post the second round of transfection. LHCNM2 cells were transfected twice 72 h apart 
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and used 72 h later.  
For some experiments cells were treated with 5 μg/ml Brefeldin A in growth media for 60 
min. prior to fixation.  
STxB-internalization was performed essentially as described (Popoff et al., 2007). 
Briefly, cells were washed in cold PBS and incubated on ice in media containing 2 μg/ml 
STxB coupled to Cy3 for 30 min. Cells were washed in cold PBS and warm media was 
added. Internalization was carried out for various times at 37°C.  
 
Hexosaminidase secretion 
 
Hexosaminidase secretion was measured based on previously described protocols 
(Riederer et al., 1994). Briefly, cells treated with siRNA as described above were washed 
in PBS and incubated in DMEM supplemented with 10mM mannose-6-phosphate for 8 h 
at 37°C. Secreted hexosaminidase activity was assayed in 0.5 ml media by addition of 
120 μl 5x hexosaminidase substrate buffer (0.5 M NaAcetate, pH 4.4, 0.5 % Triton X-
100, 5 mM p-nitrophenyl-N-acetyl--D-glucosaminide). After shaking at 37°C for 1 h, 
reactions were stopped by addition of 0.6 ml stop buffer (0.5 M glycine, 0.5 M Na2CO3, 
pH 10.0). Release of p-nitrophenol was measured spectrophotometrically at 405 nm. 
Intracellular hexosaminidase was measured by washing the cells twice in cold scraping 
buffer (10 mM phosphate buffer, pH 6.0, 0.15 M NaCl), scraping them into scraping 
buffer supplemented with 0.5 % Triton X-100 followed by centrifugation at 100,000g for 
15 min at 4°C. 50 μl of he resulting supernatant were assayed in 570 μl 1x 
hexosaminidase substrate buffer. Secreted hexosaminidase was determined as the 
percentage of the whole hexosaminidase for each sample. Secreted hexosaminidase of 
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samples was then compared to control samples and ratios were calculated.  
 
Cell fractionation and immunoblotting 
 
Cells grown and treated with siRNA as indicated above were washed in lysis buffer (100 
mM NaCl, 50 mM HEPES, pH 7.4, 5 mM MgCl2) and scraped into lysis buffer 
supplemented with protease inhibitor cocktail (1 tablet / 10 ml buffer, Roche). Cells were 
broken by subjecting them 10x to a motorized dounce homogenizer and subsequently 
shearing them four times using a 22.5 Gauge needle. Lysates were spun at 5000g to 
generate low-speed pellets (P1). The resulting supernatants were centrifuged at 
100000g to generate a high-speed pellet (P2) and a cytosolic fraction (S2). Fractions 
were taken up in reducing sample buffer and subjected to SDS-PAGE.  
Protein samples were separated by SDS-PAGE (4-12% acrylamide gel, Invitrogen), 
transferred to nitrocellulose (Millipore) and labeled with primary antibodies at 1-5 g/ml 
and secondary antibodies. The presence of antibody-labelled proteins in samples was 
detected using Western Lightning Chemiluminescence Reagent (Amersham). 
Quantification was performed using Quantity One software (Biorad).  
 
Immunofluorescence 
 
Cells grown on coverslips were washed in warm PBS, fixed in warm PFA (3.7% in PBS, 
10min), then washed (2X, 5 min, PBS), permeabilized (4 min. 3% BSA, 0.5% Triton X-
100 in PBS) and blocked in blocking solution (3% BSA in PBS, 30 min). Antibody 
labeling was performed by inversion of coverslips on 20l blocking solution with primary 
or secondary antibodies (1-5g/ml) or DAPI (300nM) on parafilm and washing with PBS. 
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Samples were mounted in Prolong Antifade Kit (Invitrogen). Some images were acquired 
on an Olympus IX80 microscope equipped with Deltavision Restoration microscope 
technology (Applied Precision Instruments, Issaquah, WA and running SoftWoRx 
(Applied Precision) deconvolution and data analysis software. Other samples were 
analyzed by confocal laser scanning microscopy using a Nikon EZ-C1Si microscope 
system equipped with an ApoPlan 100x, 1.40NA oil lens. DAPI, Alexa-488 and Alexa-
568 fluorescence was sequentially excited using lasers with wavelengths of 405 (DAPI), 
488 (Alexa 488) and 561 nm (Alexa 568). Image analysis was performed using NIS 
Elements software (Nikon) and Metamorph software (Molecular Devices). Data for this 
study were acquired at the Nikon Imaging Centers at UCSF. 
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Additional information 
 
Some data is still missing from this manuscript. These changes will be incorporated 
pending the outcome. 
 
- Fig. 2-4) immunoblot of HeLa cells downregulated for CHC17 and CHC22 probed 
with antibodies against CHC17, CHC22, TGN46, -actin 
- Fig. 2-6) will be replaced by the same experiment stained for CHC17, CHC22, 
STxB 
- Fig. 2-7) will be replaced with  
1. Fig. 2-7a: STxB uptake for 15 min. in CHC17, CHC22, SNX1-depleted 
cells stained for CHC17, CHC22, SNX1 in combination with EEAI, 
STxB 
2. Fig. 2-7b: STxB-uptake for 60 min in CHC17, CHC22, SNX1-depleted 
cells stained for CI-MPR, EEAI, StxB 
      -    Fig. 2-11a) will be replaced by the same experiment stained for CHC17, CI-MPR 
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Chapter 3 - A role for the CHC22 clathrin heavy chain isoform in glucose 
metabolism by human skeletal muscle 
 
 
The text of this chapter is a manuscript in review.  
 
 
Authors contributions: 
SV, CE, SH and FMB designed research. SV, CE and SH conducted research. BHF, 
AMP and RK created CHC22-transgenic mice. CYC designed siRNA targeting CHC22. 
WEW created LHCNM2 cells. SV, CE and FMB wrote the manuscript.  
 
Specifically, I performed research for and created figures 3-3, 3-4 and 3-9. Also, I wrote 
the corresponding passages in the manuscript, later edited and partly rewritten by FMB. 
Furthermore, I gave and received input on the rest of the figures and manuscript. The 
manuscript is presented here as a whole, as it has been a very close collaboration with 
the other authors. The work as a whole is discussed in greater context in chapter 4, with 
an emphasis on the data generated by me.   
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A role for the CHC22 clathrin heavy chain isoform in glucose metabolism by 
human skeletal muscle 
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Abstract  
 
In humans, the CHC22 isoform of clathrin heavy chain is primarily expressed in skeletal 
muscle. Although present in many vertebrates, the gene encoding CHC22 is a 
pseudogene in mice.  CHC22 is now revealed to associate with components of the 
membrane traffic pathway for the glucose transporter GLUT4 in humans.  CHC22 down-
regulation in cultured human myoblasts disrupted GLUT4 localization to an insulin-
sensitive compartment.  CHC22 expression in the muscle of transgenic mice caused 
aberrant localization of components of the GLUT4 transport pathway and induced 
symptoms of diabetes.  These studies demonstrate a role for CHC22 in formation and 
stabilization of the GLUT4 compartment in human muscle and highlight differences in 
glucose metabolism between humans and mice.  This novel function for CHC22 reveals 
a species-restricted mechanism for glucose homeostasis with potential significance to 
human type II diabetes. 
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Main text 
 
Complex tissues, such as skeletal muscle, developed specialized transport pathways by 
diversification of membrane traffic proteins through evolutionary gene duplication.  Here 
we define the tissue-specific and species-restricted function of a clathrin heavy chain 
isoform CHC22 that arose by gene duplication in the vertebrate lineage and is expressed 
in human skeletal muscle (Sirotkin et al., 1996; Wakeham et al., 2005).  The ubiquitous 
clathrin heavy chain, represented by human CHC17 (each isoform is named for the 
encoding chromosome), is expressed in all eukaryotes and in all vertebrate tissues.  In 
association with three clathrin light chain subunits, three CHC17 subunits form the well-
characterized clathrin triskelion that assembles into a protein coat for intracellular 
membrane transport vesicles (Brodsky et al., 2001; Ungewickell and Hinrichsen, 2007) .  
This lattice-like clathrin coat facilitates vesicular sorting of membrane-associated 
proteins during endocytosis and organelle biogenesis.  The CHC22 isoform also forms a 
trimer, but does not stably associate with clathrin light chains, nor interact with CHC17 
by co-trimerization or co-assembly (Liu et al., 2001; Towler et al., 2004a).  CHC22 has 
conserved features in the vertebrate lineage, indicating a conserved function, but the 
gene encoding CHC22 is a pseudogene in mice, a phenotype shared by sixteen strains 
of mice representing both laboratory and wild mice (Wakeham et al., 2005).  These 
properties led to consideration of membrane traffic pathways with suggested differences 
between human and mouse muscle cells, and thereby to investigation of a role for 
CHC22 in the membrane traffic of the glucose transporter GLUT4 (Postic et al., 2004; 
Tortorella and Pilch, 2002).  The CHC22 function reported here defines a species-
restricted mechanism for regulation of GLUT4 membrane traffic, a novel feature of 
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human glucose homeostasis with potential significance to type II diabetes and 
development of better animal models for this disease. 
 
CHC22 clathrin associates with the GLUT4 transport pathway 
 
Skeletal and cardiac muscle and adipose tissue import glucose for acute metabolic 
needs in response to insulin.  In these tissues, insulin stimulation induces cell surface 
expression of the GLUT4 transporter, causing its release from an intracellular GLUT4 
storage compartment (GSC) by fusion of GLUT4 storage vesicles (GSVs) with the 
plasma membrane. (Bryant et al., 2002; Huang and Czech, 2007).  This pathway 
enables rapid glucose clearance from the bloodstream and defects in GLUT4 membrane 
traffic are associated with type II diabetes in humans (Garvey et al., 1998).  With the 
hypothesis that some human-mouse differences in skeletal muscle glucose metabolism 
(Postic et al., 2004; Sarabia et al., 1992; Tortorella and Pilch, 2002) might be explained 
by the presence of CHC22 in humans, the distribution of CHC22 relative to GLUT4 
pathway markers was analyzed in human skeletal muscle (Fig. 3-1).  CHC22 was 
detected using previously characterized monoclonal and polyclonal antibodies that do 
not recognize CHC17 (Liu et al., 2001; Towler et al., 2004a).  The distribution of CHC22 
was distinct from CHC17 and remarkably similar to that of GLUT4 (Fig. 3-1A).  Co-
localization between CHC22 and GLUT4 was extensive though not absolute, and was 
observed in the perinuclear region of myonuclei, below the sarcolemma and in internal 
vesicles characteristic of GSVs (Ploug et al., 1998; Sarabia et al., 1992) (Fig. 3-1, A and 
B).  In the perinuclear region, CHC22 also co-localized with another marker of the GSC, 
insulin-responsive amino peptidase (IRAP) (Fig. 3-1C) (Kandror and Pilch, 1994).  
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Studies of GLUT4 membrane traffic in murine adipocytes and rodent myoblast culures 
have identified the v-SNARE VAMP2 (synaptobrevin) as a mediator of insulin-stimulated 
release of GSVs (Randhawa et al., 2000; Williams and Pessin, 2008).  VAMP2 was 
extensively co-localized with CHC22 (Fig. 3-1C).  Mouse and rat models have also 
implicated adaptor molecules that link vesicle cargo to the CHC17 clathrin coat in  
 
 
 
 
 
 
 
 
Fig. 3-1. Localization of CHC22 relative to components of the GLUT4 transport pathway 
in human skeletal muscle fibers.  Longitudinal sections of human skeletal muscle were 
processed for double immunofluorescent labeling to detect the indicated proteins and 
analyzed by confocal microscopy.  Polyclonal (rabbit) antibodies were detected with Cy3-
conjugated-anti-rabbit immunoglobulin (Ig) and monoclonal (mouse) antibodies were detected 
with Alexa488-conjugated-anti-mouse Ig.  In A and C, each row is the same sample with the 
black and white images showing staining for the individual proteins and the merge showing 
these images overlapped in color, with yellow indicating colocalization (scale bar represents 
20μm).  The far right panel in each row shows a magnified view of the region outlined in white 
on the merged image.  (A) Top panels show staining with polyclonal antibody against CHC22 
(red) and monoclonal antibody against CHC17 (green).  Bottom panels show staining with 
monoclonal antibody against CHC22 (green) and polyclonal antibody against GLUT4 (red). 
(B) X-Z and Y-Z projections of the surface-proximal confocal images in A comparing CHC22 to 
CHC17 or GLUT4 distribution.  (C) Each row shows a human skeletal muscle section labeled 
with a polyclonal antibody against CHC22 (red) and a monoclonal antibody against either 
IRAP, VAMP2, GGA2 or EEA1 (green). 
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biogenesis of the GSC, as well as in recapture of GLUT4 from the plasma membrane 
and in GSV recycling (Gillingham et al., 1999; Huang and Czech, 2007; Li et al., 2007; 
Watson et al., 2004).  In human skeletal muscle, CHC22 partially localized with one of 
these adaptors, the Golgi-localized, gamma-ear-containing, Arf-binding adaptor-2 
(GGA2) (Fig. 3-1C), suggesting that, in humans CHC22 might take over some of the 
functions mediated by CHC17 in mouse muscle.  This is certainly feasible, as CHC22 
shares 85% protein sequence identity with CHC17 and has previously been shown to 
bind the AP1 adaptor that interacts with GGA adaptors for sorting from the trans-Golgi 
network (TGN) by CHC17 (Bonifacino, 2004; Liu et al., 2001).  Notably, our previous 
studies have also shown that CHC22 does not bind the endocytic AP2 adaptor for 
CHC17 and plays no detectable role in endocytosis from the plasma membrane (Liu et 
al., 2001).  CHC22 also localized adjacent to intracellular structures marked by the early 
endosome protein EEA1 (Fig. 3-1C), suggesting CHC22 potentially functions in sorting 
from endosomes, as well as from the TGN.  These morphological results localized 
CHC22 in human skeletal muscle to structures overlapping with the GSC, as well as with 
proteins involved in GLUT4 traffic and/or formation of the GSC from the TGN and 
endosomes.  
 
Association between CHC22 and components of the GSC in human skeletal muscle was 
confirmed by biochemical analysis (Fig. 3-2).  First, membrane microsomes comprising a 
mix of all intracellular membrane compartments were prepared from human skeletal 
muscle autopsy tissue.  CHC22 fractionated predominantly with these membranes (Fig. 
3-2A).  In contrast, CHC17 and another vesicle coat protein b-COP were distributed 
between the cytosol and membrane fractions, representing disassembled and 
assembled states indicating that CHC22 is mainly in an assembled state.  Microsome 
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fractions were then separated into large membrane fragments and coated vesicles, 
using a protocol for enrichment of CHC17 coated vesicles (Fig. 3-2B).  Relative to total 
amounts of each clathrin in muscle, a smaller proportion of CHC22 (18±2.3%, n=3) was  
 
 
 
 
 
 
 
 
 
 
Fig. 3-2. Association of CHC22 with proteins involved in GLUT4 membrane traffic.  Human 
skeletal muscle was homogenized and fractionated by differential centrifugation.  Fractions were 
analyzed for the presence of the two clathrin isoforms and other membrane traffic markers 
including components of the GLUT4 transport pathway by direct immunoblotting following SDS-
PAGE separation (A and B) or by immunoprecipitation and blotting (C).  (A) Microsomal 
membrane (Mem, 20 μg) or the supernatant fraction (20 μg) corresponding to cytosolic (Cyt) 
proteins obtained during microsome preparation of were immunoblotted with antibodies 
recognizing the proteins indicated at the right.  The migration shift for AP1 likely reflects known 
phosphorylation differences between the cytosolic and membrane-bound form of the detected 1 
subunit.  (B) A clathrin-coated vesicle (CCV) fraction was prepared from microsomes (Mem) in A 
using ficoll-sucrose centrifugation known to enrich for CHC17 CCVs.  This preparation yields non-
vesicular membranes (P1), CCVs and a supernatant (S2) after P1 and CCVs are sequentially 
removed.  These fractions were analyzed with antibodies recognizing the indicated proteins.  (C) 
Microsomes (Mem in A) or CCVs isolated as in B, were solubilized in detergent for 
immunoprecipitation with the antibodies indicated at the top.  Resulting immunoprecipitates were 
analyzed by immunoblotting for the proteins indicated at the right.  For microsome lysate, the input 
material (1-2%) and an immunoprecipitate using an isotype-matched control (CTRL) antibody are 
shown. 
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detected in the coated vesicle fraction compared to CHC17 (43±3.1%, n=3).  This 
indicated that CHC22 can form coated vesicles but that it is more associated with large 
membrane compartments under steady state conditions compared to CHC17.  The 
GLUT4 traffic mediators VAMP2 and GGA2 were both found in the pool of clathrin 
coated vesicles (CCVs) and associated with larger membranes (Fig. 3-2B).  To 
determine whether these proteins were associated with CHC22 or CHC17, 
immunoisolation was performed from the microsomal or CCV fractions (Fig. 3-2C).  
GLUT4 was associated with both clathrins.  Most of the VAMP2 and GGA2, but no AP2 
adaptors were associated with CHC22.  Thus CHC22 associates with GSC cargo and 
with proteins involved in GSC formation from the TGN and endosomes, including the 
AP1 adaptor.  Lack of binding to AP2 further indicates that CHC22 is not involved in 
classical endocytosis from the plasma membrane, which appears to be a function of 
CHC17 in human skeletal muscle.  Thus, GLUT4 recapture from the plasma membrane 
of human skeletal muscle would be mediated by CHC17, as described for mouse and rat 
models (Gillingham et al., 1999; Huang et al., 2007), while CHC22 is situated to play a 
role in GSC biogenesis from internal compartments.  
 
CHC22 expression is required for formation of the GLUT4 storage compartment in 
human myotubes 
 
To investigate the suggested role for CHC22 in formation of the GSC, functional analysis 
was undertaken using LHCNM2 cells, an immortalized human skeletal muscle myoblast 
cell line, which differentiates into multinucleated myotubes upon removal of serum (Fig. 
3-3, 3-4) (Zhu et al., 2007).  Immunofluorescence analysis of multinucleated myotubes 
revealed GLUT4 partially overlapping with CHC22 and to a lesser extent with CHC17 
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Fig. 3-3. Requirement for CHC22 in GSC formation and insulin-responsiveness in 
cultured human myotubes.  LHCNM2 human myoblasts were differentiated into myotubes, 
then treated with siRNA targeting CHC17 or CHC22 or with non-specific (control) siRNA (A-F). 
Samples were analyzed by immunofluorescence and immunoblotting, and for insulin-
responsiveness.  (A-F)  Each set of three represents the same sample after treatment with 
siRNA (knock down (KD) specificity indicated at the left), processed for double 
immunofluorescence.  Black and white images represent labeling by individual antibodies 
(indicated above the sample) and merge shows both together with an inset showing 
magnification of the boxed area.  Antibodies to CHC17 and CHC22 are detected with Alexa488-
conjugated-anti-mouse Ig and Alexa488-conjugated-anti-rabbit Ig (green) respectively and 
antibody to GLUT4 is detected with Alexa568-conjugated-anti-goat Ig (red).  Yellow indicates 
overlap. Scale bars, 20 μm.  (G) Whole cell lysates of differentiated LHCNM2 cells treated with 
siRNA (target specificity indicated above the lanes) were separated by SDS-PAGE and the 
proteins indicated at the right were detected by immunoblotting.  (H) Glucose-uptake in 
response to insulin was assessed in differentiated LHCNM2 cells treated with siRNA (target 
specificity indicated below each bar). Insulin-stimulated glucose-uptake was normalized to non-
stimulated controls (n=5).  Asterisk indicates a statistically significant difference. 
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Fig. 3-4.  Further analysis of GLUT4 membrane traffic and glucose metabolism in 
human myotubes.  LHCNM2 were grown under differentiation conditions to form myotubes 
and analyzed as follows.  (A and B) Myotube cultures were processed for double 
immunofluorescent labeling with antibodies to GLUT4 detected with Alexa568-conjugated-anti-
goat Ig (red) and with antibodies to EEA1 or TGN46 detected with Alexa488-conjugated-
secondary antibodies against mouse or rabbit Ig, respectively (green).  Scale bars, 20 μm.  (C) 
Myotube cultures were treated with siRNA targeting CHC17 or CHC22 or with control siRNA, 
as indicated below each bar.  Basal levels of glucose uptake by each treated culture were 
measured and normalized to basal levels of glucose-uptake by control siRNA-treated cultures 
(n=5). Asterisks indicate statistically significant differences.  (D) Myotube cultures were treated 
with siRNA targeting CHC17 or CHC22 or with non-specific (control) siRNA.  Each set of three 
micrographs represents the same sample after treatment with siRNA (knock down (KD) 
specificity indicated at the left), processed for double immunofluorescence.  Black and white 
images represent labeling by individual antibodies (indicated above the micrograph) and 
merge shows both together with an inset showing magnification of the boxed area.  Antibodies 
to GLUT1 are detected with Alexa488- conjugated-anti-rabbit Ig (green) and antibody to 
GLUT4 is detected with Alexa568- conjugated-anti-goat Ig (red).  Yellow indicates overlap. 
Scale bars, 20 μm. 
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(Fig. 3-3, A and D). Hardly any GLUT4 was detectable in mononucleated myoblasts.  In 
myotubes, GLUT4 did not overlap with markers of the early endosome (EEA1) or the 
TGN (TGN46) (fig. 3-4A, B), suggesting that the GLUT4 detected in myotubes had a 
distribution typical of the GSC.  LHCNM2 cells were transfected with siRNA and high 
knock-down efficiencies observed (Fig. 3-3G). CHC22 downregulation led to a strong 
reduction of GLUT4 staining and apparent loss of the GSC (Fig. 3-3, C and F, Fig. 3-4D). 
In contrast, downregulation of CHC17 slightly reduced the intensity of the intracellular 
GLUT4 signal in myotubes (Fig. 3-3, B and E), without changing GLUT4 localization.  
This is consistent with a role for CHC17 in recapture of GLUT4 from the plasma 
membrane by endocytosis (Huang et al., 2007). The distribution of the constitutively 
expressed GLUT1 transporter was not affected by downregulation of either CHC (Fig. 3-
4D).  Cells treated with siRNA against CHC17 regularly showed increased levels of 
CHC22 protein, while a slight increase in CHC17 upon CHC22 depletion was variable 
(Fig. 3-3G).  These changes likely reflect increased stability from increased membrane 
association of each clathrin when the other is absent, because they compete for some 
shared membrane-associated adaptors.  It is notable that the level of GLUT4 protein 
increased upon CHC17 depletion and decreased upon CHC22 depletion, while GLUT1 
levels were unchanged (Fig. 3-3G).  GLUT4 increase could be explained by greater 
stability of the GSC when CHC22 levels increase upon CHC17 depletion, and the 
GLUT4 decrease following CHC22 depletion explained by an alteration in trafficking and 
diversion to lysosomes in the absence of the GSC.  In sum, these siRNA depletion 
experiments indicate an essential and specific role for CHC22 in biogenesis of the GSC.  
 
Previous studies of GLUT4 membrane traffic in cell cultures have established that the 
only way to detect endogenous GLUT4 recruitment to the plasma membrane from the 
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GSC is to measure changes in glucose uptake upon insulin stimulation.  This approach 
is mandated because endogenous GLUT4 that can be detected in internal vesicles 
becomes diffuse and undetectable once exported to the plasma membrane so insulin-
induced recruitment cannot be measured morphologically (Ishiki et al., 2005). Thus, a 
glucose uptake assay was performed on differentiated LHCNM2 cultures transfected 
with siRNA targeting the two clathrins (Fig. 3-3H) as a way of assessing integrity and 
function of the GSC.  The assay measures cellular uptake of radioactive glucose 
following insulin stimulation relative to glucose uptake under basal conditions.  The basal 
uptake is due to the unregulated, constitutive expression of the GLUT1 transporter (9).  
In cultures that received non-targeting siRNA, insulin treatment induced a 50% increase 
in glucose uptake compared to non-stimulated cells.  This contrasts with similar 
experiments performed on the mouse C2C12 cell line, which did not show any insulin-
response (Tortorella and Pilch, 2002), suggesting human myotubes have a more robust 
GLUT4 response to insulin compared to murine counterparts.  CHC22-depleted 
LHCNM2 myotubes did not have an insulin-stimulated response.  Their glucose uptake 
showed no difference between insulin-stimulated or basal conditions (ratio of 1.0) (Fig. 3-
3H), consistent with loss of the GSC following CHC22 depletion (Fig. 3-3, C and G, Fig. 
3--4D).  Depletion of CHC17 from the LHCNM2 human myotubes caused a small, but 
not statistically significant, reduction in insulin sensitivity, with a 40% increase in glucose 
uptake after insulin treatment (Fig. 3-3H).  This effect is explained by decreased 
recapture of GLUT4 by CHC17 resulting in a decreased intracellular pool.  In keeping 
with this explanation, the basal rate of glucose uptake by cultures depleted for CHC17 
was increased (fig. 3-4C), likely reflecting higher basal levels of GLUT4 on the cell 
surface when endocytosis is inhibited.  Interestingly, CHC22 depleted myotubes also 
exhibited increased basal glucose uptake.  This effect is likely due to lack of 
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sequestration of GLUT4 in the GSC during biosynthesis since CHC22 does not affect 
endocytosis (Liu et al., 2001).  
 
CHC22-transgenic mice show diabetic symptoms 
 
Analysis of human muscle and myoblasts suggests that the presence of CHC22 and its 
role in GSC formation might account for some of the documented differences in glucose 
uptake by mouse and human muscle cells (Sarabia et al., 1992; Tortorella and Pilch, 
2002).  To investigate the differences in GSC formation and function between mouse 
and human muscle, we analyzed three strains of mice transgenic for a bacterial artificial 
chromosome (BAC) comprising the human gene CLTCL1 (formerly CLTD) encoding 
CHC22, under the control of its own muscle-specific promoter (Fig. 3-5A).  The BAC 
included only one other adjacent gene encoding the citrate transporter SLC25A1 that is 
already present in the mouse genome.  Muscle-specific expression of the CHC22 
transgene was verified by immunoblotting tissues from the CHC22-transgenic mice (Fig. 
3-5E).  The initial expectation was that the CHC22-mice might clear bloodstream glucose 
more efficiently because they share components of the human GLUT4 trafficking 
pathway with which CHC22 is able to interact.  However, when glucose and insulin 
tolerance tests were performed, results were opposite to those expected (Fig. 3-6).  
These were most dramatic in older CHC22-mice (ages 25 to 50 weeks), which showed 
diabetic symptoms in all three strains of transgenic mice.   The older CHC22 mice were 
hyperglycemic compared to age and weight matched wild-type mice (Fig. 3-6A) and 
displayed signs of insulin resistance.  The insulin-induced glucose clearance of mice 
older than 20 weeks was decreased relative to insulin-induced clearance in age-matched 
wild-type mice (Fig. 3-6, B and C).  Additionally, for all ages of mice tested, clearance of 
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injected glucose from the bloodstream (Fig. 3-6, D and E) was slightly less efficient in the 
CHC22-mice compared to wild-type mice. 
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Fig. 3-5.  Production and characterization of the CHC22 transgenic mice.  (A) The genomic 
interval contained within BAC339F21 is shown.  This BAC was used to produce CHC22 
transgenic mice.  Open boxes represent the SP6 and T7 ends of vector pBACe3.6.  Filled boxes 
symbolize CHC22 exons.  Above, solid arrows indicate the transcriptional orientation of genes 
present on the BAC (CHC22 and SLC25A1).  Dashed lines indicate partial genes (HIRA and 
GSCL).  Filled circles represent PCR markers used to genotype the founder animals to assess 
integrity of the genomic interval and the solid line underneath shows the location of the probe 
used for Southern hybridization.  (B) Southern blot analysis of the CHC22 transgenic mice. 
Genomic DNA from transgenic lines 3, 10, 7 and 41 (two animals from each), as well as from 
two wild type (WT) animals was analyzed with a probe corresponding to the human CHC22 
locus (top blot) as well as a probe corresponding to a single copy locus on mouse chromosome 
16 (bottom).  The transgenic lines used for experiments described in this manuscript are marked 
with an asterisk.  (C) Northern blot analysis of the CHC22 transgenic mice.  A probe 
corresponding to CLTCL1 exons 6-10 was generated by RT PCR and hybridized to 25 mg of 
RNA from skeletal muscle (left) or testis (right), isolated from each line indicated above the RNA 
samples.  Human RNA (HU) from skeletal muscle or testis (Clontech) served as a positive 
control and RNA isolated from skeletal muscle and testis of wild type (WT) mice as a negative 
control.  The transgenic lines used for experiments described in this manuscript are marked with 
an asterisk.  (D) RT-PCR analysis of human CHC22 (CLTCL1)  and SLC25A1 transcripts in 
skeletal muscle (SM) or testis (T) from lines 3, 10, 7 and 41 or WT mice.  RT-PCR was also 
used to detect transcription of the mouse mitochondrial ribosomal protein L40 (Mrpl40) (mouse 
control).  This control shows that RNA was present in all samples tested, including the WT 
mouse samples that were negative for amplification human CLTCL1 and SLC25A1.  Human 
skeletal muscle cDNA was used as a positive control for the expression of the human genes 
(second from right lane of top two gels).  Genomic mouse DNA (gen) was used as a negative 
control for RNA amplification, as well as the absence of reverse transcriptase (RT).  Sizing 
markers are in the far right hand lane for all three gels.   
(E) The expression of CHC22 protein was analyzed by immunoblotting tissue lysates from wild-
type (WT) or CHC22 transgenic mice (22).  Each indicated tissue was harvested, homogenized 
and solubilized in detergent and 50 mg was loaded in each lane.  The migration position of the 
160 kDa molecular weight marker protein is indicated at the left of the blot.   
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Fig. 3-6. Symptoms of diabetes in CHC22 transgenic mice.  CHC22 transgenic mice and age-
matched wild-type mice were fasted and their blood glucose levels measured directly (A) or 
following injection of insulin (B and C) or following injection of glucose (D and E).  (A) Blood 
glucose level of wild type (WT, n=10) and CHC22 transgenic mice (22, n=10 representing all three 
strains) after 6 hours of fasting.  (B and C) CHC22 transgenic mice of all three strains () or their 
wild type littermates () of age <20 weeks or > 20 weeks were fasted for 6 hours, then injected 
with insulin.  Blood was collected from their tail vein at the indicated time after injection and 
glucose levels were measured.  (D and E) CHC22 transgenic mice of all three strains () or their 
wild type littermates () of age <20 weeks or > 20 weeks were fasted for 16 hours, then injected 
with glucose (2g/kg body weight).  Blood was collected from the tail vein at the indicated time after 
injection and glucose levels measured   The curves show average glucose levels of 6 to 10 mice. 
Statistical analysis was performed using Students t-test. Asterisks indicate points that are 
statistically different from each other (P<0.05).  Error bars represent ±SEM.  (F)  Skeletal muscle 
lysate (40 μg) from CHC22 transgenic strain 2 (22) or age-matched wild-type (WT) littermates 
were analyzed for expression of proteins involved in GLUT4 membrane traffic by immunoblotting 
with antibodies against proteins indicated at the right, including phosphorylated AKT (p-AKT), total 
AKT and GAPDH, as a control.  The age of the mice analyzed is indicated above the lanes.  (G) 
Expression levels of proteins detected in F relative to GAPDH for CHC22 transgenic mice or wild-
type littermates, all older than 25 weeks. (n=6 for each mouse strain, error bar represents SD, 
p<0.05, asterisks indicate statistically significant differences). 
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The hyperglycemic and insulin resistance phenotypes of the transgenic mice suggest 
changes in the GLUT4 membrane traffic pathway.  To characterize these changes at the 
protein level, skeletal muscle homogenates were analyzed for expression of proteins 
involved in GLUT4 transport and glucose metabolism.  Increased levels of 
phosphorylated AKT (pAKT) and of VAMP2 were detected in the skeletal muscle of the 
CHC22-mice compared to muscle from age-matched wild type mice (Fig. 3-6, F and G).  
This phenotype was stronger in older CHC22-mice (25 weeks vs 8 weeks) and was 
observed for all three strains of CHC22-transgenic mice (Fig. 3-8A).  Other proteins 
including total AKT, GLUT4, IRAP, the SNARE Vti1a and CHC17 showed no change in 
level with age or presence of the transgene in all strains (Fig. 3-6, F and G, and Fig. 3-
8A).  Thus, the increased level of pAKT (phosphorylation at serine 473 detected by 
specific antibody) was not due to an increase in total AKT protein.  Rather, it is a 
hallmark of increased signaling in the GLUT4 export pathway, sometimes observed in 
diabetic conditions (Lizcano and Alessi, 2002; Manning and Cantley, 2007).  While 
insulin levels were not significantly elevated in the transgenic mice (data not shown), 
their increase in pAKT indicates hyperactivity of the signaling pathway leading to GLUT4 
export (Ng et al., 2008) and suggests a compensatory response to disruption of that 
pathway.  The slight increase in GLUT1 levels in the transgenic mice (Fig. 3-8A) could 
also reflect a compensatory pathway responding to their need for increased glucose 
clearance.  These phenotypes are unlikely to be caused by the only other BAC-encoded 
transgene, SLC25A1 (formerly CTP), a citrate transporter (Palmieri et al., 1996) that is 
expressed naturally from the BAC promoter (fig. 3-5D) and has an existing function in 
mice.  The altered glucose metabolism in the transgenic mice is more feasibly explained 
by a direct effect of the presence of CHC22 clathrin.  The elevated level of VAMP2 in the 
transgenic mice is indicative of altered membrane traffic in the presence of CHC22.  
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Since VAMP2 participates in GLUT4 release, its altered traffic would impair insulin-
stimulated glucose metabolism by disruption of GSC function. 
 
Aberrant sequestration of GLUT4 membrane traffic components in CHC22-
transgenic mice 
 
The disruption of GLUT4 membrane traffic by expression of CHC22 in mouse skeletal 
muscle was confirmed by morphological analysis.   Isolated muscle fibers from the 
transgenic mice showed that GLUT4, IRAP and VAMP2 were localized to swollen GSC-
like structures (Fig. 3-7A).  These structures, revealed by serial optical sections of fibers 
stained for immunofluorescence, were visible as extensive bright patches just 
underneath the plasma membrane and were not seen in wild-type mouse muscle fibers.  
Further analysis of muscle fibers showed CHC22 co-localized with GLUT4 and IRAP in 
these compartments (Fig. 3-83B) and that GLUT1 was excluded (Fig. 3-8C), indicating 
abnormal expansion of the GSC in the CHC22-transgenic mice relative to wild-type mice.  
To confirm that the presence of CHC22 could be responsible for excessive sequestration 
of VAMP2 and GLUT4 in these enlarged compartments, the biochemical interaction 
between CHC22 and murine components of the GLUT4 trafficking pathway was 
assessed for mouse muscle (Fig. 3-7B).  VAMP2, GLUT4 and GGA2 co-
immunoprecipitated with CHC22 from transgenic mouse muscle, while less GLUT4, no 
VAMP2 and very little GGA2 were detected in association with CHC17 in either 
transgenic or wild-type mouse muscle.  As seen for human muscle, the endocytic 
adaptor AP2 segregated with CHC17 and not CHC22.  In muscle, the majority of GLUT4 
export and subsequent endocytosis occurs at T-tubules (Zhu et al., 2007).  
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Fig. 3-7.  Analysis of GLUT4 membrane traffic in CHC22 transgenic mice. (A) Skeletal 
muscle fibers were isolated and cultured from (WT) or CHC22 transgenic mice (22) (6 weeks 
old).  These were analyzed by immunofluorescence using antibodies against GLUT4, VAMP2 
and IRAP, detected with Alexa488-conjugated secondary antibody. Scale bar represents 20 μm. 
(B) Skeletal muscle lysate (of whole tissue) from wild type (WT) or transgenic CHC22 mice (22) 
was used for immunoprecipitation (IP) with antibodies against CHC22, CHC17 or an isotype-
matched control (CTRL) antibody.  Immunoprecipitates were analyzed for the proteins indicated 
at the right by immunoblotting.  Starting lysate (Lys, 1%) of CHC22 mouse muscle is shown.  (C) 
Fractionation of plasma membrane and T-tubules from wild-type (WT) or CHC22 transgenic 
mice (22).  Equal amounts of protein from each fraction were analyzed by immunoblotting with 
antibodies against proteins indicated at the right, including the T-tubule marker dihydropyridine 
receptor (DHPR) and the plasma membrane marker Na/K-ATPase.  These data represent 
results from all three CHC22-transgenic mouse strains. 
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Fig. 3-8.  Components of GLUT4 membrane traffic pathway in CHC22 transgenic mice 
and comparison to GLUT1 expression.  (A) Skeletal muscle lysate (of whole tissue) (40 μg) 
from CHC22 transgenic (22) or age-matched wild-type (WT) littermates was analyzed for 
expression of proteins involved in GLUT4 membrane traffic by immunoblotting with antibodies 
against proteins indicated at the right, relative to GAPDH, as a control.  The levels of SNARE 
protein Vti1a and GLUT1 were also measured.  The age of the mice analyzed is indicated above 
the lanes.  The CHC22 transgenic mice analyzed in this experiment were derived from strains 7 
(40 weeks) and strain 10 (60 weeks), while the samples analyzed in Fig. 5 were from strain 2, 
demonstrating that VAMP2 and pAKT were elevated in all CHC22-transgenic strains.  (B, C and 
D) Muscle fibers from CHC22 transgenic (all strains) (22) or WT mice were processed for double 
immunofluorescent labeling by antibodies recognizing the indicated proteins and analyzed by 
confocal microscopy.  Polyclonal antibodies against GLUT4, CHC22 and GLUT1 were detected 
with Cy3-conjugated-anti-rabbit Ig (red) and monoclonal antibodies against IRAP, CHC22 and 
AP2 were detected with Alexa488-conjugated-anti-mouse Ig (green).  Each row of micrographs 
is the same sample with the black and white images showing staining for the individual proteins 
and the merge showing these images overlapped in color, with yellow indicating colocalization. 
Scale bars, 20μm. 
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The clathrin adaptor at these membranes is AP2 (fig. 3-8D), which shows a distribution 
pattern typical of the T-tubules. These biochemical and morphological data further 
dissociate CHC22 function from plasma membrane and T-tubule endocytosis and point 
to a role in GSC generation from the TGN and endosomes in human skeletal muscle.  
When this CHC22 function is introduced into mice, which form the GSC without it, their 
GSC is altered and GLUT4 transport is perturbed.  
 
Recent studies have implicated CHC17 in membrane traffic of several SNARE proteins 
(Borner et al., 2006; Miller et al., 2007).  The strong association of CHC22 with VAMP2 
in both human and transgenic mouse skeletal muscle suggests an orthologous role for 
CHC22 in VAMP2 traffic, which would affect VAMP2 targeting in the CHC22-mice, 
explaining its increased stability.  To investigate the possibility that excessive 
sequestration of VAMP2 affects GLUT4 recruitment to the plasma membrane, levels of 
GLUT4 associated with the plasma membrane (PM) and T-tubule (TT) membranes were 
assessed (Fig. 3-7C).  Membranes from transgenic and wild-type mouse muscle were 
fractionated by differential centrifugation and the identity of the PM and TT fractions 
confirmed by the respective presence of the Na/K-ATPase and the dihydropyridine 
receptor.  Both membrane fractions from the CHC22 transgenic mice had reduced levels 
of GLUT4 associated with them relative to levels detected in wild-type mice.  Overall, the 
analysis of GLUT4 distribution in the muscle of CHC22 transgenic mice confirms its 
inappropriate sequestration in an intracellular compartment with VAMP2 and IRAP 
resulting in lower expression at the PM and TT.  This reduction in steady state levels of 
surface of GLUT4 indicates that the ongoing insulin response of CHC22-transgenic 
mouse muscle is defective for GLUT4 release compared to wild-type mice, explaining 
the hyperglycemia and insulin resistance of the transgenic mice.   
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Model for species-restricted clathrin function in human glucose metabolism 
 
Here we demonstrate that CHC22 clathrin is required for generation of the GSC in 
human myoblasts and influences membrane traffic of GLUT4, IRAP and VAMP2, three 
components of the GSC.  The data indicate that CHC22 and its association with the 
GGA2 adaptor are involved in diversion of these components from the TGN and possibly 
endosomes to the GSC, but that CHC22 is not involved in GLUT4 endocytosis (Fig. 3-
9A, steps 3, 2 and 1, respectively).  In spite of this key role for CHC22 in GSC formation 
in humans, it is absent from mouse skeletal muscle and its artificial presence disrupts 
the function of the mouse GSC to the extent of inducing some diabetic symptoms.  
These observations raise the questions of how do mice organize their GSC since they 
lack CHC22 and how does murine GSC formation relate to what occurs in human 
skeletal muscle?  From the studies of GSC formation in rodent cells, it is clear that 
GGAs, AP1 and CHC17 play important roles in diverting GLUT4 to the GSC from the 
constitutive secretory pathway via the TGN, and other adaptors seem to be involved in 
GLUT4 diversion from endosomes back to the GSC (Li et al., 2007; Watson et al., 2004).  
These pathways are clearly sufficient to produce a functional GSC in mouse skeletal 
muscle (Fig. 3-9B).  We propose that in the skeletal muscle of the CHC22-transgenic 
mice (Fig. 3-9C), CHC22 competes for CHC17 binding to GGA2 as it must do in human 
cells, and excessively sequesters cargo targeted to the GSC such that GLUT4 and 
VAMP2 cannot be normally released in response to insulin (Fig. 3-8, step 4).  Problems 
with GLUT4 release could be due to CHC22 interfering with the normal equilibrium 
between exocytosis and endocytosis that allows the GSC to function in mice.  GSVs 
formed in the presence of CHC22 could have an altered composition that affects their 
ability to be released or mice may lack additional factors needed to regulate CHC22.  
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Syntaxin 10 and TBC1D3 are other examples of membrane traffic proteins missing from 
mice but present in humans, setting a precedent for potential species-restricted proteins 
that could be needed for CHC22 function (Frittoli et al., 2008; Ganley et al., 2008; 
Wainszelbaum et al., 2008).  We note that, in contrast to CHC17, which is about 50% 
Fig. 3-9. Proposed roles for CHC22 and 
CHC17 clathrins in GSC formation in 
human, wild-type mouse and CHC22-
transgenic mouse skeletal muscle. 
Transport steps are indicated by numbers: 
(1) endocytosis from the plasma membrane, 
(2) endosome to GSC, (3) TGN to GSC and 
(4) insulin-induced exocytosis.  (A) In human 
muscle, CHC22 is the main clathrin 
responsible for diversion of GLUT4, VAMP2 
and IRAP (not shown) into the GSC from the 
TGN and possibly endosomes, using the 
GGA2 adaptor.  CHC17 functions in retrieval 
of GLUT4 from the plasma membrane.  (B) In 
wild-type mouse, the GSC can form, but 
since CHC22 is lacking, the GSC is less 
stable and more dependent on equilibrium 
between endocytosis, biogenesis and 
secretion.  In this situation, CHC17 clathrin 
mediates all the adaptor dependent steps for 
sorting GLUT4.  (C) In CHC22-transgenic 
mouse, CHC22 competes with CHC17 for 
interactions with GGA2 adaptors and over-
stabilizes the GSC, causing its expansion, 
disruption of the normal equilibrium in mouse 
and trapping of GSC components, resulting 
in aberrant GLUT4 function. 
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cytosolic, CHC22 is mainly membrane associated at steady state.  In addition, despite its 
interaction with AP1 and GGA2, CHC22 is not dissociated from intracellular membranes 
by treatment of cells with Brefeldin A, a drug which disrupts CHC17 binding to the TGN 
(data not shown).  These properties suggest that CHC22 confers greater stability to 
tubules or vesicles containing GSC components than those formed only in the presence 
of CHC17, expanding the human GSC compared to that in rodents (Fig. 3-9, A and B).  
This would correlate with a relatively more robust GLUT4-mediated response to insulin in 
human myoblasts and muscle compared to the response in mice (Sarabia et al., 1992; 
Tortorella and Pilch, 2002) and with the excessive sequestration of GSC components in 
the transgenic mice (Fig. 3-9C).   
 
While much has been learned from mouse models about glucose metabolism that is 
relevant to human diabetes, the studies reported here highlight some important species-
specific differences that will facilitate better understanding of the human disease.  By 
demonstration that GLUT4 membrane traffic differs between human and mouse muscle, 
our findings could help explain why 70-90% of insulin-stimulated glucose clearance 
depends on skeletal muscle in humans (Postic et al., 2004; Shepherd and Kahn, 1999), 
but in mice, the liver is the most influential organ controlling insulin responsive glucose 
reduction in the bloodstream (Bruning et al., 1998; Michael et al., 2000).  Notably 
however, our findings still verify a role for mouse skeletal muscle in insulin-stimulated 
glucose clearance since disruption of GLUT4 traffic in mouse skeletal muscle by 
introduction of CHC22 results in some symptoms of diabetes.  Finally, the ability of 
CHC22 to partially carry out its function in transgenic mice raises the possibility of 
rescuing the rest of its function and creating a better mouse model in which human 
glucose metabolism and diabetes can be studied. 
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Materials and methods 
 
Antibodies 
 
One monoclonal and one polyclonal antibody that specifically recognize CHC22 and not 
CHC17 have been described (Liu et al., 2001). A second polyclonal antibody against 
amino acids 1549-1563 from human CHC22 was raised by contract (New England 
Peptides). The antibody was purified negatively and positively, using recombinantly 
expressed trimerization domain fragments of human CHC17 and CHC22, respectively, 
coupled to NHS-Hi-Trap columns (Amersham) and specificity for CHC22 was confirmed 
by immunoblotting the recombinant fragments.  Commercial sources of antibodies were 
as follows: mouse monoclonal anti-VAMP2 (Synaptic Systems), rabbit polyclonal anti-
GLUT4 (Calbiochem), goat polyclonal anti-GLUT4 (Santa Cruz), mouse monoclonal anti-
GLUT4 (Sigma), rabbit polyclonal anti-GLUT1 (Abcam) and antibodies to GGA3, TGN46, 
EEA1, COP1, AP1 and Vti1a (Transduction Laboratories). Anti-CHC17 (mouse 
monoclonals X22 and TD.1 and rabbit polyclonal against clathrin light chains) and anti-
AP2 (AP6) antibodies used in this study were produced by our laboratory and 
extensively characterized in the literature (references available upon request). 
Monoclonal anti-GGA1 and GGA2 antibodies were gifts from Juan Bonifacino (NIH, 
Bethesda) with permission from John Hopwood (Womens and Childrens Hospital, 
Adelaide), and monoclonal anti-IRAP antibody was a gift from Morris Birnbaum 
(University of Pennsylvania, Philadelphia).  Secondary antibodies for 
immunofluorescence were from Molecular Probes (Alexa488, Alexa568 conjugate) and 
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Jackson Immunoresearch (Cy3-conjugates). Secondary antibodies coupled to HRP were 
from Zymed Laboratories. 
 
Muscle tissue lysate and microsome preparation 
 
Membrane microsomes or lysate of whole tissue were prepared from human (fresh 
autopsy sample) or mouse skeletal muscle (freshly dissected).   For muscle lysate, 
tissue was homogenized with a polytron (3 times 5s, speed 5) in lysis buffer (1gm/7ml 50 
mM Tris-HCl pH 7.5, 0.15 M NaCl, 1 mM EDTA, 1% NP40 and 1 protease inhibitor 
cocktail tablet (1/10ml buffer, Roche, Indianapolis, IN)).  Homogenate was centrifuged 
(10 min, 14,000 x g) and the pellet discarded.  Protein concentration of the lysate was 
determined by Bradford assay (Biorad).  For membrane microsomes, tissue was 
homogenized by dounce (1-2gm/10 ml 200 mM sucrose, 20 mM HEPES pH 7.4, 0.4 mM 
CaCl2, 2 mM leupeptin, 100 mM phenylmethylsulfonyl fluoride (PMSF) and the low-
speed (10 min, x 1,400 g) pellet discarded.  Resulting supernatant was centrifuged (50 
min, 41,000 x g), yielding microsomes in the pellet and a soluble fraction. The 
microsome pellet was resupsended in 0.1 M NaCl, 30 mM imidazole pH 6.8, 8% sucrose 
with protease inhibitors at a final concentration of 8-10 mg/ml and stored at -80°C.  
Immunoblotting for marker proteins revealed the presence of plasma membrane (AP2 
adaptor), endoplasmic reticulum (calnexin) and Golgi (b-COP) membranes in the 
microsome fraction and by shared sedimentation properties indicated the presence of all 
cellular membranes (Fig. 2).   
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Clathrin coated vesicle (CCV) isolation 
 
Human or mouse skeletal muscle microsomes, prepared and stored as above, were 
diluted (2.5 mg/ml) in ice-cold Buffer A (0.1 M MES pH 6.5, 0.2 mM EGTA, 0.5 mM 
MgCl2, 0.02% NaN3, 0.2 mM PMSF) and the suspension mixed with an equal volume of 
12.5% Ficoll/12.5% sucrose in buffer A, then centrifuged (25 min, 21,000 x g).  The 
supernatant was diluted with four volumes of Buffer A, and CCVs were pelleted (30 min, 
136,000 x g), then resuspended in 30–100 μl buffer A using a 0.1-ml hand-held glass 
homogenizer.  
 
Plasma membrane and T-tubule isolation 
 
Mouse skeletal muscle microsomes were applied to a discontinuous sucrose gradient 
(25, 32 and 35%, w/w in Buffer A and centrifuged (150,000 x g, 16 h).  Membranes at the 
sample/25% interface (plasma membrane, PM) and the 32/35% interface (transverse 
tubules, TT) were recovered, diluted with sucrose-free Buffer A and centrifuged (190,000 
x g,1 h) (Dombrowski et al., 1996).  These membrane fractions were analyzed in Fig. 5C.  
The PM fraction was further purified by binding to wheat germ agglutinin to eliminate 
endosomal membranes (Munoz et al., 1995).  Analysis of these membranes by 
immunoblotting confirmed a reduction in PM levels of GLUT4 in the CHC22 transgenic 
mice compared to wild-type mice (data not shown).  
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Immunoblot analysis 
 
Protein samples were separated by electrophoresis (4-12% acrylamide gel), then 
electrophoretically transferred to nitrocellulose (Millipore) and labeled with primary 
antibodies at 1-5 mg/ml and secondary antibodies coupled to horseradish peroxidase 
(Jackson ImmunoResearch Laboratories). The presence of CHC22 or other proteins in 
samples was detected using Western Lightning Chemiluminescence Reagent 
(Amersham).  Quantification was performed using Quantity One software (Biorad). 
 
Immunoprecipitation 
 
Human skeletal muscle microsomes or mouse skeletal muscle tissue lysate were diluted 
to 500 μg/ml or 3mg/ml respectively in lysis buffer (50 mM Tris-HCl pH 7.5, 0.15 M NaCl, 
1 mM EDTA, 1% NP40 and 200 μM PMSF), precleared with 20 μl washed Protein-G-
Sepharose (PGS 4 fast flow, Amersham Biosciences) per 400 μl of diluted microsomes 
or lysate, and incubated with 20 μg of specific antibody overnight (4°C). Then 20 μl 
washed PGS added and incubated for 1 hr at 4°C, followed by washing (3X with lysis 
buffer).  Pelleted PGS was taken up in sample buffer and subjected to electrophoresis 
and immunoblotting. 
 
Dissociated fiber cultures 
 
Myofibers were isolated from the dissected flexor digitorum brevis muscle of 6-wk old 
mice by digestion with collagenase 1a (Worthington Biochemical Corp.) and mechanical 
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dissociation (Kaisto et al., 1999).  Isolated fibers were cultured (37°C, 5% CO2) in 
Dulbeccos Modified Eagle medium (DMEM) with high glucose, 1% horse serum 
(GIBCO), and penicillin/streptomycin on coverslips coated with Matrigel (Becton 
Dickinson Labware, Bedford, MA).  Myofibers were used for experiments after overnight 
culture.  
 
Human myoblast cultures 
 
LHCNM2 human skeletal muscle cells (Zhu et al., 2007) were maintained in tissue 
culture flasks coated with rat-tail collagen in basal medium (4:1 DMEM:M199, 0.02M 
HEPES, 0.03 μg/ml ZnSO4, 1.4 μg/ml Vitamin B12) with 10% fetal bovine serum (FBS), 
55ng/ml dexamethasone, 2.5ng/ml hepatocyte growth factor (Sigma), 50 U/ml penicillin, 
50 mg/ml streptomycin, 0.625 μg/ml fungizone (growth medium).  Differentiation was 
induced by culturing in fusion medium (basal medium with 0.5% FBS, 10 μg/ml insulin, 
50 μg/ml apo-transferrin and 5.5 ng/ml dexamethasone) followed by differentiation 
medium (basal medium with 0.5% FBS, 55 ng/ml dexamethasone).  Differentiation 
medium was applied as soon as multinucleated myotubes appeared in the culture, 
normally after about 7 days and cells were differentiated for an additional 7 days.  After 
this procedure, approximately 30% of the myoblasts were fused into multinucleated 
myotubes. For siRNA treatment, cells were transfected twice 72h apart using 10nM 
siRNA and HiPerfect transfection reagent (Qiagen) according to manufacturers 
instructions. Targeting and non-specific control siRNAs were synthesized by Qiagen. 
DNA sequences targeted were AAGCAATGAGCTGTTTGAAGA for CHC17 and 
TCGGGCAAATGTGCCAAGCAA and AACTGGGAGGATCTAGTTAAA for CHC22 (1:1 
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mixture of siRNAs were used).  Experiments were performed 72h after the final 
transfection. 
 
Immunofluorescence microscopy 
 
Adult human or mouse skeletal muscle was embedded in Tissue-Tek OCT compound 
(Miles Inc.), frozen, and stored at -80°C. Cryosections (10 μm thick) collected on 
microscope slides were fixed (15 min, 4% paraformaldehyde in PBS, RT), washed (2X, 
10 min, PBS, 4°C), permeabilized (5 min, 0.5% Triton X-100 in PBS, RT) and blocked 
(30 min, PBS with 0.1% Triton X-100, 0.5% bovine serum albumin (BSA)).  Sections 
were incubated with primary antibodies (overnight, 4°C, 2-5 mg/ml in PBS with 0.1% 
Triton X-100, 0.5% BSA) and washed (3X, 10 min, 4°C, PBS with 0.1% Triton X-100). 
Sections were then incubated with secondary antibodies (manufacturers dilutions, 30 
min, RT), washed (3X, 10 min, PBS with 0.1% Triton X-100, RT), and mounted with anti-
fading solution (DABCO) containing DAPI (300 nM). For double labeling, the two primary 
antibodies (from different species) or the two secondary antibodies were added 
simultaneously at the appropriate step.  Secondary antibodies were labeled with either 
Alexa-488, Alexa-546 (Molecular Probes), or Cy3 (Jackson ImmunoResearch 
Laboratories).  For myofibers isolated from mouse muscle, immunolabeling was 
performed directly in the 24-well culture plate. Cells were fixed (15 min, 4% 
paraformaldehyde in PBS, RT) washed (2X, 5 min, PBS), permeabilized (10 min. PBS 
with 0.5% Triton X-100), and immunolabeled using the same procedure described for 
human and mouse muscle sections.  For LHCNM2 cells grown on coverslips, cells were 
washed in warm PBS, fixed in warm PFA (3.7% in PBS, 10min), then washed (2X, 5 
min, PBS), permeabilized (4 min. 3% BSA, 0.5% Triton X-100 in PBS) and blocked in 
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blocking solution (3% BSA in PBS, 30 min).  Antibody labeling was by inversion of 
coverslips on 20μl blocking solution with primary or secondary antibodies (1-5μg/ml) or 
DAPI (300nM) on parafilm and washing with PBS.  Samples were mounted in Prolong 
Antifade Kit (Invitrogen).  Muscle sections, LHCNM2 cells and myofibers from mouse 
muscle were analyzed by confocal laser scanning microscopy using a Nikon EZ-C1Si 
operating system  an ApoPlan 100x, 1.40NA oil lens.  DAPI, Alexa-488, Alexa-568, or 
Cy3 fluorescence was sequentially excited using lasers with wavelengths of 405 (DAPI), 
488 (Alexa 488) and 561 nm (Alexa 568, Cy3). Z-series from the top to the bottom of 
fibers were sequentially collected for each channel with a step of 0.9-1μm between each 
frame.  Data for this study were acquired at the Nikon Imaging Centers at UCSF. 
 
Glucose uptake assay 
 
Glucose uptake assays were based on published procedures (Li and Kandror, 2005).  
Fully differentiated LHCNM2 cells were stimulated with 100nM insulin in differentiation 
medium for 10 min, washed twice with warm Krebs-Ringer-Henseleit (KRH) solution 
(121mM NaCl, 4.9mM KCl, 1.2mM MgSo4, 0.33mM CaCl2, 12mM HEPES), followed by 
addition of warm 0.1mM 2-Desoxyglucose in KRH with 1mCi/ml 3[H]-2-Desoxy-Glucose 
for 5 min and reactions stopped by addition of ice-cold 25mM 2-Desoxyglucose in KRH.  
Cells were then washed twice with KRH, 4°C and lysed in 0.1% SDS in KRH.  To 
determine non-specific glucose uptake, 5mM Cytochalasin B (CytB) was included when 
3[H]-2-Desoxy-Glucose was added in parallel samples.  Protein concentration of lysates 
were determined using Bradford reagent (Biorad) and radioactivity measured by 
scintillation counting. The ratio of insulin-stimulated glucose uptake to basal glucose 
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uptake was calculated using the following equation, where A is activity measured in cpm: 
(Ainsulin – Ainsulin + CytB) / Abasal – Abasal + CytB). 
 
Generation of BAC transgenic mice 
 
BAC339F21 containing the CLTCL1 gene was isolated from the RPCI11 BAC library 
(www.chori.org/bacpac).  The ends were sequenced to determine the exact boundaries.  
DNA for pronuclear injections was isolated using the Endo-free Plasmid Maxi Kit 
(Qiagen) and transferred into injection buffer (10mM Tris HCl ph 7.5, 0.1 mM EDTA, 
100mM NaCl) using a pre-equilibrated sepharose CL4b column.  Circular BAC DNA was 
injected into the pronucleus of fertilized FVB zygotes at a concentration of 3 ng/ml.  
Injections were performed by the Transgenic Core at the Dana Farber Cancer Institute.  
Founders were identified by PCR using vector-specific primers for pBACe3.6 (BACT7-F 
AATGCTCATCCGGAGTTCC and BACT7-R ACTGGTGAAACTCACCCAGG).  Five 
founders were generated (#2, 3, 7, 10, 41) and further analyzed by PCR using human 
specific PCR primers across the region (fig. S2).  All five founders contained all markers 
(data not shown). 
 
Genetic analysis of transgenic lines 
 
Approximate transgene copy numbers were determined by Southern blot hybridization 
using a human intragenic CLTCL1 probe (intron 6-7) and a mouse probe corresponding 
to a single copy locus from mouse chromosome 16 (BAC72mu2-F: 
TAGCCACTCCACAAGGCAG and BAC72mu2-R: CCCTGAGCTACGTCTTCTGG).  
After transfer of the genomic DNA to a nylon membrane, the membrane was cut and the 
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probes detecting human or mouse genes were hybridized separately to the resulting 
membrane pieces each of which comprised the target fragments.  For Northern analysis, 
a probe corresponding to CLTCL1 exons 6-10 was generated by RT PCR and hybridized 
to 25 mg of total RNA.  Human RNA from skeletal muscle and testis (Clontech) served 
as a positive control (fig. S2).  Line 41 generated an aberrant transcript (data not shown) 
and was therefore excluded from further analyses.  
 
Glucose and insulin tolerance tests 
 
Mice were fasted (14 to 16 hrs), then injected intraperitoneally with D-glucose (1 mg/gm 
body weight).  Blood was collected from the tail vein prior to injection (time 0) and 15, 30, 
60, 90 and 120 min post-injection.  Glucose levels were measured using a Freestyle 
Flash Glucometer (Abbott).  For insulin tolerance tests, fasted mice were administered 
recombinant insulin (bovine, Sigma) intraperitoneally (1 U/kg of body weight in 0.9% 
NaCl solution), and glucose levels were measured at 15, 30, 45 and 60 min post-
injection. 
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Chapter 4 - Discussion and further directions 
 
In this study I explored the functions of a novel clathrin heavy chain isoform, CHC22. 
Although it displays 85% sequence identity to CHC17, its well-characterized homologue, 
both clathrin heavy chains do not function together, nor can they substitute for one 
another. Instead, both act independently in different sorting pathways in the cell for 
specific cargo.  
 
Studies in HeLa 
 
HeLa cells were used to compare CHC17 and CHC22-function side by side. Hela cells 
are advantageous for these studies, since they represent a non-specialized cell model. 
Furthermore, Hela are readily maintained in culture and protocols for performing a 
variety of assays is readily available. Indeed, HeLa is the cell model of choice for 
numerous membrane traffic studies.  
I could demonstrate that CHC22 neither acts together with, nor substitutes for CHC17 
function. This is consistent with previous data generated in the Brodsky laboratory (Liu et 
al., 2001; Towler et al., 2004a). CHC22 involvement in various functions mediated by 
CHC17 was tested for including clathrin-mediated endocytosis and mitotic spindle 
recruitment. Further studies of functions of CHC17 in membrane traffic at the TGN and 
early endosomes, as defined by the early endosome antigen EEAI, indicated that 
CHC22 is not directly involved in these either, despite possible interactions with the 
relevant clathrin adaptors AP1 and AP3. However, I revealed a function for CHC22 in 
sorting of cargo in an endosomal compartment. Both M6PR- and Shiga-Toxin-trafficking 
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were inhibited in a post early endosomal compartment as defined by the absence of 
EEAI on M6PR- and STxB-containing vesicles in CHC22-depleted cells. This contrasts 
with TGN46 trafficking, which was influenced by CHC17- but not CHC22-depletion. This 
places CHC22 function downstream of CHC17 function in endosomal sorting.  
 
STxB has been crucial in defining endosomal sorting pathways, since it tafficks in a 
unidirectional manner from the plasma membrane via early endosomes to the TGN 
(Mallard et al., 1998). Subsequent studies defined a role for CHC17 in STxB sorting in 
EEAI-positive early endosomes (Saint-Pol et al., 2004) which was reproduced in this 
study. Recently, it was proposed that CHC17 and retromer act synergistically in STxB 
export from EEAI-positive endosomes as depletion of retromer results in accumulation of 
STxB in EEAI-negative tubules emanating from EEAI-positive structures. Formation of 
these tubules also required CHC17 (Popoff et al., 2007). Depletion of CHC22 led to 
accumulation of STxB in EEAI-negative vesicles. Notably, STxB was found on EEAI-
positive structures after 15 min. of internalization even in CHC22-depleted cells, stongly 
suggesting that a block in its trafficking occurred in a compartment downstream of EEAI-
positive early endosomes. 
 
M6PR accumulated in the same compartment in CHC22-depleted cells, suggesting that 
is shares these vesicles with STxB. In contrast to STxB, M6PR is blocked in the TGN in 
CHC17-depleted cells, due to its export from the TGN being CHC17-mediated, an effect 
previously described in the literature (Hinrichsen et al., 2003; Meyer et al., 2000). Also, 
SNX1-depletion impairing retromer function on M6PR-trafficking resulted in accumulation 
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of the receptor in EEAI-positive early endosomes, again mirroring published data (Arighi 
et al., 2004; Seaman, 2004).  
 
The third trafficking molecule that I assessed was TGN46. Its retrograde trafficking from 
endosomes to TGN required CHC17 but not CHC22, the depletion of which did not result 
in any change on TGN46 localization or protein stability. In addition, I did not detect any 
effect of SNX1-depletion on TGN46, in agreement with current literature (Arighi et al., 
2004; Bujny et al., 2007; Franch-Marro et al., 2008) contrasting with one report 
describing fragmented Golgi staining of TGN46 in retromer depleted cells (Seaman, 
2004). This suggests that retrograde trafficking of TGN46 is CHC17-mediated but 
independent of retromer and CHC22 function. This places TGN46 endosome exit 
upstream of the latter two activities.  
 
Studies in LHCNM2 
 
CHC22 expression is highest in skeletal muscle and upregulated in skeletal muscle 
differentiation. Therefore, skeletal muscle specific functions for CHC22 were 
hypothesized, as muscle displays several tissue-specific membrane trafficking pathways 
utilizing muscle-specific isoforms of ubiquitous trafficking molecules (Towler et al., 
2004b). To test for muscle-specific functions of CHC22, LHCNM2 cells were cultivated. 
This cell line is an immortalized cell line derived from primary human myoblasts (Zhu et 
al., 2007). LHCNM2 myoblasts displayed the ability to differentiate into multinucleated 
myotubes upon the removal of serum. In addition, the fusion process was highly 
dependent on the concentration of dexamethasone in the media. These cells are not as 
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versatile as HeLa cells and grow very slowly. In comparison to the commonly used 
skeletal muscle cell lines C2C12 (derived from mouse) or L6 (derived from rat), LHCNM2 
grow more slowly and fusion is less effective at about 30 - 40 % fused nuclei to 70 - 80 
% in C2C12 (Fulco et al., 2008). Nonetheless, some key experiments could be 
performed in LHCNM2 cells, as they allowed for effective depletion of proteins using 
siRNA and displayed robust insulin-induced glucose-uptake. Notably, depletion of either 
clathrin heavy chain did not result in altered differentiation properties when compared to 
control cells.  
 
One muscle-specific trafficking pathway is the formation of the GLUT4-storage 
compartment (GSC). This specialized compartment accumulates GLUT4 glucose 
transporter under basal conditions, to release it in the presence of insulin, rapidly 
increasing the concentration of glucose transporter on the cell surface. GLUT4 is 
trafficked to the GSC from both TGN for newly synthesized protein and endosomes for 
protein recycled from the plasma membrane.  
 
When comparing LHCNM2 cells depleted of either clathrin heavy chain with control cells, 
I found that CHC22 but not CHC17 is required for formation of the GSC. This was 
observed both by immunofluorescence, and in a glucose-uptake assay testing function 
of the GSC. GLUT4-staining, found throughout the cytoplasm in control and CHC17-
depleted cells indicative of the vesicular nature of the GSC, was abolished in CHC22-
depleted cells.  This strongly suggests that a GSC is not formed in these cells. Total 
GLUT4-levels were also decreased in CHC22-depleted cells, presumably due to 
increased lysosomal degradation caused by missorting resulting from to the lack of 
CHC22. Translocation of GLUT4 measured by increased glucose uptake in control cells 
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stimulated with insulin when compared to basal conditions, was not observed in CHC22-
depleted cells further demonstrating the lack of a functional GSC. CHC17 depletion did 
not affect either GSC-formation or function.  
 
CHC17 has been shown to at least partly mediate GLUT4 endocytosis (Antonescu et al., 
2008; Huang et al., 2007). CHC17 involvement in sorting of GLUT4 at the TGN and 
endosomes has not been directly demonstrated. However, a role for monomeric CHC17 
adaptors, the GGAs, has been described in TGN export of GLUT4 (Watson et al., 2004; 
Watson and Pessin, 2008). A comparable function for GGAs in endosome export of 
GLUT4 is currently discussed in the literature, with conflicting data being available so far 
(Li and Kandror, 2005; Watson and Pessin, 2008). Notably all of this data was gathered 
in rodent cell lines, which do not express CHC22. Data from our laboratory indicates that 
GGA2 associates more strongly with CHC22 than with CHC17 in human tissue samples. 
Taken together, the available data defines roles for both clathrin heavy chains in distinct 
trafficking steps of GLUT4 in humans.  
 
Model of endosomal sorting of various cargos by clathrin heavy chains 
 
Trying to fit all the data available into one model for endosomal trafficking has been 
challenging, starting with the nature of the compartment itself. Extreme ideas range from 
segregated vesicular membranes to one large network termed the “tubular endosomal 
network” (Bonifacino and Rojas, 2006; Maxfield and McGraw, 2004). Notably, temporal 
distinction between CHC17-, retromer- and CHC22-function could be possible in both 
models proposed. Also, in all of these considerations one has to take into account the 
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possibility, that different cargoes are not necessarily sorted together and sorting one 
cargo out of a compartment leaves this compartment behind with a different protein 
composition and potentially different reactivity. For example, EEAI-positive endosomes 
that were described earlier as carrying M6PR, STxB and GLUT4 also carry Tfr-R and 
EGF-R at some point in their trafficking to the plasma membrane and lysosomes 
respectively. Other protein determinants have been defined as being required for their 
transport such as SNX4 for Tfr-R-recycling (Traer et al., 2007) or the ESCRT protein 
complexes for EGF-R (Williams and Urbe, 2007). Nonetheless, the use of different 
model cargoes defining specific trafficking routes seems to be a good approach to try to 
understand endosomal trafficking. Here I try to summarize our current understanding of 
these processes (Fig. 4-1) and to highlight potential alternative pathways and open 
questions.  
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Fig. 4-1: Model of endosomal trafficking. Model depicting endosomal sorting and 
maturation from early to late endosomes in humans from left to right, with cargo arriving 
from the plasma membrane and the TGN. 
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The model assumes that cargo arrives in EEAI-positive early endosomes and is 
subsequently sorted to their respective target membranes. Immediately upon arrival at 
this endosomal stage, Tfr-R is recycled back to the plasma membrane via recycling 
endosomes. Mediators of this sorting step include SNX4 (Traer et al., 2007), and ACAP1 
(Li et al., 2007). Recycling of Tfr-R was initially described as being clathrin-independent 
(Mayor et al., 1993), although this view has recently been challenged (Li et al., 2007). In 
contrast, recycling of TGN46 to the TGN seems to be CHC17-dependent but retromer- 
and CHC22-independent (shown in this study), suggesting its rapid export from early 
endosomes. Notably, STX6 has been demonstrated to be required for retrograde sorting 
of TGN46 (Ganley et al., 2008).  
 
The role of CHC17 and retromer in M6PR and STxB exit from the EEAI-positive early 
endosome has been discussed above. Subsequently a role for CHC22 has been 
demonstrated in this study. Details of further trafficking of M6PR and STxB remain 
unclear, however these two cargoes have to separate in a downstream step. STxB is 
thought to traffic from an early endosomal compartment directly to the TGN (Mallard et 
al., 1998), while M6PR traffic via late endosomes (Lombardi et al., 1993). STX6 and 
STX10 have recently been used to distinguish between these two pathways (Ganley et 
al., 2008).  
 
Based on the blocking effect of CHC22-depletion on M6PR and STxB-trafficking 
occurring in an EEAI-negative compartment, I hypothesize that GLUT4 sequestration to 
the GSC occurs in the same compartment. While CHC22-depletion results in GSCs not 
being formed, it prevents or at least slows down further maturation of the M6PR and 
STxB-containing compartment. This places the CHC22-dependent step downstream of 
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sorting from the EEAI-positive compartment and upstream of sorting M6PR and STxB 
from one another. Since CHC22-depletion does not affect TGN46 trafficking, the EEAI-
positive early endosome seems largely unaffected. This begs the question, how is 
GLUT4 exported from this compartment? On one hand, comparisons to M6PR and STxB 
suggest, that GLUT4 is also retrieved from EEAI-positive endosomes by means of 
CHC17 and retromer. On the other hand, it has been demonstrated that GLUT4 is 
ubiquitinated and GGAs are potentially involved in its exit from EEAI-positive 
endosomes. In case of the EGF-R, GGAs have been demonstrated to bind the 
ubiquitinated receptor which is subsequently exported from early endosomes (Piper and 
Luzio, 2007; Puertollano and Bonifacino, 2004; Scott et al., 2004). However, 
ubiquitinated EGF-R is degraded in lysosomes, while GLUT4 is sequestered into the 
GSC. This would require the deubiquitination of GLUT4 to save it from lysosomal 
degradation. Given such a deubiquitination activity exists, it remains unclear if this 
activity is present in GSCs or endosomes and if CHC22 sorts ubiquitinated or 
deubiquitinated GLUT4. Further experimentation into the exit of GLUT4 from EEAI-
positive early endosomes is therefore required. GLUT4 has also been shown to be 
sumoylated, which also affects the insulin-response in these cells (Giorgino et al., 2000) 
but the physiological relevance of this event is unknown.  
 
Another way to look at the problem of GLUT4 exiting the EEAI-positive endosome is to 
ask, how CHC22 is recruited onto GLUT4-containing vesicles. CHC22 associates with 
GGA2 in adult skeletal muscle suggesting that GGA2 could recruit CHC22 onto 
membranes. Also, CHC22 has been demonstrated to bind SNX5 (Towler et al., 2004a), 
which has been suggested to be part of the retromer complex (Wassmer et al., 2007). I 
gathered some preliminary data suggests CHC22 could also bind SNX1. One possible 
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mode of action for CHC22 could be to stabilize vesicles derived from early endosomes 
en route to late endosomes and the TGN. Structural analyses of retromer revealed it 
forming tubules (Hierro et al., 2007). However, tubules have not yet been observed to 
connect endosomes and TGN. Possibly, retromer derived tubules fall apart and are 
subsequently stabilized by CHC22. One could imagine a hand-off model in which 
retromer components SNX1 and SNX5 recruit CHC22, which subsequently binds GGAs, 
that are still bound on the emerging tube. Consistent with this idea is SNX5 binding the 
proximal leg of CHC22 and GGAs potentially binding the terminal domain of CHC22. 
Upon recruitment, CHC22 could act in sorting GLUT4 out of the newly formed vesicles. 
 
A stabilizing effect as outlined above would shift the balance in dynamics of this pathway 
towards the newly formed vesicle but not fundamentally change the actual pathway. This 
fits well with CHC22-depletion only having a moderate effect in overall efficiency of 
M6PR trafficking when compared to CHC17-depletion. Also, this is consistent with mice 
having a functional, although less robust GSC. Furthermore, in mice adipocytes about 40 
% of GLUT4 is found in a Tfr-R containing compartment, defined as early endosomes 
(Karylowski et al., 2004). In contrast, virtually no colocalization was found between EEAI 
and GLUT4 in LHCNM2 cells and human tissue samples, strongly arguing for a more 
complete diversion of GLUT4 from early endosomes.  
 
Future directions 
 
As outlined above there are still very many questions concerning CHC22-function. The 
exact characterization of CHC22 behaviour in cells regarding binding and regulation is 
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largely elusive at this point. Ideally, electron microscopy would be performed on cells 
immunolabelled for CHC22. Also, other cargo molecules should be tested for their 
dependence on CHC22. That way it should be possible to further pinpoint CHC22 
function regarding the exact temporal order in endosomal sorting as well as its exact 
localization. 
 
Largely ignored in this study is the biochemistry of CHC22. A great deal of information 
has been gathered about CHC17 by in vitro studies using the purified protein or 
fragments thereof (Fotin et al., 2004; Liu et al., 1995; Ungewickell and Branton, 1981; 
Ungewickell and Ungewickell, 1991; Ybe et al., 1999). Recently, a protocol has been 
published for purification of recombinant full-length CHC17 in insect cells (Rapoport et 
al., 2008). Similar approaches could be used to purify CHC22 or fragments of CHC22. In 
contrast to CHC17, which is highly expressed in brain, CHC22 is predominantly 
expressed in skeletal muscle, which is readily available from bovine and chicken. 
However, while antibodies against CHC17 recognize the bovine isoform, antibodies 
raised against human CHC22 failed to recognize bovine or chicken CHC22. A new 
antibody raised against a peptide of human CHC22 has not been tested against chicken 
CHC22 yet. Comparing the human and corresponding chicken sequences (amino acids 
1549-1563), there are two amino acid changes (position 1551: Q to E; position 1563: R 
to Q) making it unlikely but possible, that this antibody recognizes chicken CHC22. In 
this case a protocol could be established that purifies CHC22-coated vesicles, possibly 
involving an immunoisolating step using CHC22-specific antibody to exclude CHC17-
coated vesicles. CHC22-coated vesicles could subsequently be analyzed in mass 
spectrometry to determine their protein content. Also, CHC22 could be purified from 
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coated vesicles by dissociating the vesicles and performing size exclusion 
chromatography.  
In case of expression of recombinant protein fragments, a 6xHis-sequence could be 
used to trace the protein. With purified protein in hand, various tests could be performed 
regarding assembly characteristics and membrane association. Protocols for such 
experiments are already exemplified by comparable experiments on CHC17.  
 
Probably the most interesting question is why mice have lost CHC22 and how they 
compensate for this loss. Answering this would give us a better understanding of current 
mouse models for diabetes, and help us create better models with respect to the human 
situation. Also, it would shed light on CHC22 function in humans. Since mice transgenic 
for human CHC22 display an extended but non-functional GSC, it is conceivable that 
mice lack additional factors required for GSC function compared to humans. One such 
candidate is human STX10, which is not present in the mouse genome. mRNA 
expression of STX10, while found in all tissues, is increased in pancreas, heart and 
skeletal muscle (Tang et al., 1998). STX10 is a SNARE-protein of the syntaxin family, 
and like STX6 is involved in fusion of retrograde endosomal transport vesicles to the 
TGN. Interestingly, there are a number of reports from various labs implicating STX6 in 
endosomal sorting of GLUT4 (Perera et al., 2003; Shewan et al., 2003; Watson and 
Pessin, 2008). This data was collected in rodent models. As noted previously, STX6 and 
STX10 have been used to distinguish retrograde pathways of STxB and M6PR (Ganley 
et al., 2008). While this study demonstrated functions for STX6 and STX10 at the TGN, it 
also suggested that both syntaxins could play a role in inner-endosomal fusion events. 
Therefore one approach will be to express STX10 alongside CHC22 in mouse skeletal 
muscle. The mouse skeletal muscle cell line C2C12 can be used in these experiments. 
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Native C2C12 do not show any response to insulin with respect to glucose uptake 
(Tortorella and Pilch, 2002) - a notable contrast to LHCNM2 human skeletal muscle and 
one of the main arguments for a more robust GSC in humans. Potentially, an insulin-
response could be triggered by expression of CHC22 and STX10 in these cells. Another 
cell system to use would be primary muscle cells from mice transgenic for CHC22. 
CHC22-transgenic mice already show an expanded GSC, which is non-functional. 
Adding STX10 could potentially reinstate function of the enlarged GSC. Ideally, a stable 
cell line from CHC22-transgenic mice would be established, which can then be used for 
screening several candidates for reinstating a functional GSC. Since primary cells can 
be difficult to transfect, a stable cell line expressing CHC22 would also guarantee a 
consistent background for subsequent transfection studies.  
 
Another candidate for reinstating correct GSC function in mice expressing CHC22 is 
TBC1D3, a regulator of EGF-R signaling through ERK and Akt-kinases Like STX10 
TBC1D3 is non-existent in mice (Hodzic et al., 2006; Wainszelbaum et al., 2008). 
Interestingly, the TBC1D3 gene is located close to the CHC17 gene in the human 
genome (17.12 and 17q11-qter, respectively). Since GSC-activation is mediated in an 
Akt-dependent mechanism, one could imagine a requirement for TBC1D3 in this 
process. Also, TBC1D3 has been demonstrated to interact with GGA3 and to be 
involved in macropinocytosis (Frittoli et al., 2008). However, TBC1D3 is only present in 
hominoid species, therefore lacking from several vertebrates that express CHC22.  
 
Finally, it could be possible that CHC22 is involved in cellular processes other than 
endosomal traffic. One potentially relevant related membrane pathway is 
macropinocytosis. As mentioned above TBC1D3 is involved in EGF-stimulated 
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macropinocytosis via an interaction with GGA3. Notably, the unique interaction partner of 
CHC22, SNX5, as well as SNX1 have also been shown to be involved in 
macropinocytosis (Bryant et al., 2007; Kerr et al., 2006). These studies have been 
carried out in the human cell lines MCF-7 and HEK, which contain readily detectable 
CHC22-levels. Besides SNX1 and SNX5, newly formed macropinocytic compartments 
contain the early endosomal marker EEAI (Kerr et al., 2006). Macropinosomes mature 
rapidly as the late endosomal marker Rab7 can be detected on them within 2-4 minutes 
after establishment (Racoosin and Swanson, 1993), before they eventually fuse with 
lysosomes. Potentially, CHC22 may play an analogous role in macropinosome 
maturation as it does in endosome maturation. The field of macropinocytosis will likely 
become even more prominent with the recent high profile discovery of vaccinia virus and 
potentially other pox viruses inducing membrane ruffling and macropinocytosis as a 
means to gain cell entry (Mercer and Helenius, 2008).  
 
In conclusion, I demonstrated CHC22 to be required for endosomal sorting of various 
cargoes in epithelial and skeletal muscle cells and for generation of the specialized 
glucose storage compartment in skeletal muscle. Thereby a novel sorting pathway 
independent of CHC17 has been defined. This pathway is critical for insulin activity and 
glucose homeostasis in humans and therefore of clinical relevance for type 2 diabetes. 
Further investigations will aim at better understanding of the molecular mechanism 
involved in CHC22 function and deepen our understanding of human type 2 diabetes.  
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